Prof. G.R.A.M. D'Haens PhD publications

2021

• D'Haens Geert R., van Deventer Sander 25 years of anti-TNF treatment for inflammatory bowel disease: Lessons from the past and a look to the future Gut 2021 [PubMed]
• Stellingwerf M. E., Bemelman W. A., Löwenberg M., Ponsioen C. Y., D'Haens G. R., van Dieren S., Buskens C. J. A nationwide database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy? Colorectal disease 2021;23 (1):64-73 [PubMed]
• Marquès Camí Miquel, Serracarbasa Alba, D'Haens Geert, Löwenberg Mark Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic Review Frontiers in Medicine 2021;7 [PubMed]
• Strik Anne S., Löwenberg Mark, Mould Diane R., Berends Sophie E., Ponsioen Cyriel I., van den Brande Jan M. H., Jansen Jeroen M., Hoekman Daniël R., Brandse Johannan F., Duijvestein Marjolijn, Gecse Krisztina B., de Vries Annick, Mathôt Ron A., D’Haens Geert R. Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial Scandinavian journal of gastroenterology 2021;56 (2):145-154 [PubMed]
• Rivière Pauline, D'Haens Geert, Peyrin-Biroulet Laurent, Baert Filip, Lambrecht Guy, Pariente Benjamin, Bossuyt Peter, Buisson Anthony, Oldenburg Bas, Vermeire S. verine, Laharie David Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX American journal of gastroenterology 2021;116 (1):134-141 [PubMed]
• Dreesen Erwin, Berends Sophie, Laharie David, D'Haens Geert, Vermeire S. verine, Gils Ann, Mathôt Ron Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease British journal of clinical pharmacology 2021;87 (1):106-118 [PubMed]

2020

• Koelink Pim J., Bloemendaal Felicia M., Li Bofeng, Westera Liset, Vogels Esther W. M., van Roest Manon, Gloudemans Anouk K., van't Wout Angelique B., Korf Hannelie, Vermeire S. verine, te Velde Anje A., Ponsioen Cyriel Y., D'Haens Geert R. A. M., Verbeek J. Sjef, Geiger Terrence L., Wildenberg Manon E., van den Brink Gijs R. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling Gut 2020;69 (6):1053-1063 [PubMed]
• Berends Sophie. E. Anti-TNF therapy in inflammatory bowel disease: Towards personalized medicine 2020. 251p. ISBN 9789090325651. [UvA Dissertations Online] University of Amsterdam. (Supervisors: D'Haens Geert. R. A. M., Mathot Ronald. A A.; Co-supervisor: Lowenberg Mark)
• Hoekman Daniël R., Löwenberg Mark, van den Brink Gijs R., Ponsioen Cyriel Y., Benninga Marc A., D'Haens Geert R. A prospective study comparing patient-reported outcomes in Crohn's disease European journal of gastroenterology & hepatology 2020;32 (1):38-44 [PubMed]
• Reinisch Walter, Panaccione Remo, Bossuyt Peter, Baert Filip, Armuzzi Alessandro, Hébuterne Xavier, Travis Simon, Danese Silvio, Sandborn William J., Schreiber Stefan, Berg Sofie, Zhou Qian, Kligys Kristina, Neimark Ezequiel, Suleiman Ahmed A., D'Haens Geert, Colombel Jean-Frederic Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study Inflammatory bowel diseases 2020;26 (10):1562-1571 [PubMed]
• van Wassenaer Elsa A., Diederen Kay, van Leeuwen Ester M. M., D'Haens Geert R., Benninga Marc A., Koot Bart G. P., Kindermann Angelika Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment? Journal of clinical gastroenterology 2020 [PubMed]
• Pasha Shabana F., Pennazio Marco, Rondonotti Emanuele, Wolf Douglas, Buras Matthew R., Albert J. rg G., Cohen Stanley A., Cotter Jose, D'Haens Geert, Eliakim Rami, Rubin David T., Leighton Jonathan A. Capsule Retention in Crohn's Disease: A Meta-analysis Inflammatory bowel diseases 2020;26 (1):33-42 [PubMed]
• Wasmann Karin A, Study group members AMC , Buskens Christianne J., Bemelman Willem A., Hompes Roel, Tanis Pieter J., D'Haens Geert, Dolmaci Onur B., Groen Jip, van der Bilt Jarmila , Ponsioen Cyriel, Duijvestein Marjolijn, Lowenberg Mark, Wildenberg Manon E., Gecse Krisztina B. Complications While Waiting for IBD Surgery-Short Report Journal of Crohn s & colitis 2020;14 (2):277-280 [PubMed]
• Lewis James D., Rutgeerts Paul, Feagan Brian G., D'haens Geert, Danese Silvio, Colombel Jean-Frederic, Reinisch Walter, Rubin David T., Selinger Christian, Bewtra Meenakshi, Barcomb Lisa, Lacerda Ana P., Wallace Kori, Butler James W., Wu Meijing, Zhou Qian, Liao Xiaomei, Sandborn William J. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease Inflammatory bowel diseases 2020;26 (2):304-313 [PubMed]
• Ungaro Ryan C., Yzet Clara, Bossuyt Peter, Baert Filip J., Vanasek Thomas, D'Haens Geert R., Joustra Vincent Wilhelmus, Panaccione Remo, Novacek Gottfried, Reinisch Walter, Armuzzi Alessandro, Golovchenko Oleksandr, Prymak Olga, Goldis Adrian, Travis Simon P., Hébuterne Xavier, Ferrante Marc, Rogler Gerhard, Fumery Mathurin, Danese Silvio, Rydzewska Grazyna, Pariente Benjamin, Hertervig Erik, Stanciu Carol, Serrero Melanie, Diculescu Mircea, Peyrin-Biroulet Laurent, Laharie David, Wright John P., Gomollón Fernando, Gubonina Irina, Schreiber Stefan, Motoya Satoshi, Hellström Per M., Halfvarson Jonas, Butler James W., Petersson Joel, Petralia Francesca, Colombel Jean-Frederic Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease Gastroenterology 2020;159 (1):139-147 [PubMed]
• Abreu Maria T., Sandborn William J., Cataldi Fabio, D'Haens Geert, Feagan Brian G., Hanauer Stephen, Jairath Vipul, Lakatos Peter, Leptak Christopher, McGovern Dermot, Mulberg Andrew, Panes Julian, Parikh Asit, Peyrin-Biroulet Laurent, Reinisch Walter, Riddell Robert, Rubin David, Sands Bruce, Spleiss Johannes, Strauss Richard, Tole Swati, Tomaino Juli Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design Gastroenterology 2020;159 (6):2013-2018.e7 [PubMed]
• D'Haens Geert, Kelly Orlaith, Battat Robert, Silverberg Mark S., Laharie David, Louis Edouard, Savarino Edoardo, Bodini Giorgia, Yarur Andres, Boland Brigid S., Afif Waqqas, Li Xiao-jun, Hale Michael, Ho Jessica, Kondragunta Venkateswarlu, Huang Benjamin, Kuy Crystal, Okada Lauren, Hester Kelly D., Bray Kurtis R., Mimms Larry, Jain Anjali, Singh Siddharth, Collins Angelina, Valasek Mark A., Sandborn William J., Vermeire Severine, Dulai Parambir S. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins Gastroenterology 2020;158 (3):515-526.e10 [PubMed]
• Ma Christopher, Sandborn William J., D'Haens Geert R., Zou Guangyong, Stitt Larry W., Singh Siddharth, Ananthakrishnan Ashwin N., Dulai Parambir S., Khanna Reena, Jairath Vipul, Feagan Brian G. Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis Clinical gastroenterology and hepatology 2020;18 (8):1760-1768.e1 [PubMed]
• Sandborn William J., Ferrante Marc, Bhandari Bal R., Berliba Elina, Feagan Brian G., Hibi Toshifumi, Tuttle Jay L., Klekotka Paul, Friedrich Stuart, Durante Michael, Morgan-Cox MaryAnn, Laskowski Janelle, Schmitz Jochen, D'Haens Geert R. Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis Gastroenterology 2020;158 (3):537-549.e10 [PubMed]
• Sandborn William J., Feagan Brian G., Loftus Edward V., Peyrin-Biroulet Laurent, van Assche Gert, D'Haens Geert, Schreiber Stefan, Colombel Jean-Frederic, Lewis James D., Ghosh Subrata, Armuzzi Alessandro, Scherl Ellen, Herfarth Hans, Vitale Lauren, Mohamed Mohamed-Eslam F., Othman Ahmed A., Zhou Qian, Huang Bidan, Thakkar Roopal B., Pangan Aileen L., Lacerda Ana P., Panes Julian Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease Gastroenterology 2020;158 (8):2123-2138.e8 [PubMed]
• Sandborn William J., Ghosh Subrata, Panes Julian, Schreiber Stefan, D'Haens Geert, Tanida Satoshi, Siffledeen Jesse, Enejosa Jeffrey, Zhou Wen, Othman Ahmed A., Huang Bidan, Higgins Peter D. R. Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis Gastroenterology 2020;158 (8):2139-2149.e14 [PubMed]
• van Rijn Kyra L., Lansdorp Corine A., Tielbeek Jeroen A. W., Nio C. Yung, Buskens Christianne J., D'Haens Geert R. A. M., Löwenberg Mark, Stoker Jaap Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease Clinical imaging 2020;59 (2):179-187 [PubMed]
• Tilg Herbert, D'Haens Geert How to Manage Crohn's Disease After Ileocolonic Resection? Gastroenterology 2020;159 (3):816-820 [PubMed]
• Lansdorp Corine A., Gecse Krisztina B., Buskens Christianne J., Löwenberg Mark, Stoker Jaap, Bemelman Willem A., D’Haens Geert R.A.M., van Hulst Rob A. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease Alimentary pharmacology & therapeutics 2020 [PubMed]
• van Aalst Mariëlle, Garcia Garrido Hannah M., van der Leun Josephine, Meek Bob, van Leeuwen Ester M. M., Löwenberg Mark, D'Haens Geert R., Ponsioen Cyriel Y. I., Grobusch Martin P., Goorhuis Abraham Immunogenicity of the Currently Recommended Pneumococcal Vaccination Schedule in Patients With Inflammatory Bowel Disease Clinical infectious diseases 2020;70 (4):595-604 [PubMed]
• van Gennep Sara, de Boer Nanne K. H., Gielen Marieke E., Rietdijk Svend T., Gecse Krisztina B., Ponsioen Cyriel Y., Duijvestein Marjolijn, D’Haens Geert R., Löwenberg Mark, de Boer Angela G. E. M. Impaired Quality of Working Life in Inflammatory Bowel Disease Patients Digestive diseases and sciences 2020 [PubMed]
• Dulai Parambir S., Battat Robert, Barsky Maria, Nguyen Nghia H., Ma Christopher, Narula Neeraj, Mosli Mahmoud, Vande Casteele Niels, Boland Brigid S., Prokop Larry, Murad M. Hassan, DʼHaens Geert, Feagan Brian G., Sandborn William J., Jairath Vipul, Singh Siddharth Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors American journal of gastroenterology 2020;115 (6):885-894 [PubMed]
• de Vries Leonie C. S. Janus kinase inhibition in the treatment of inflammatory bowel disease 2020. 170p. ISBN 9789493197237. [UvA Dissertations Online] University of Amsterdam. (Supervisors: D'Haens Geert R. A. M., de Jonge Wouter J.; Co-supervisor: Wildenberg Manon E.)
• Stevens Toer W., Haasnoot Maria L., D'Haens Geert R., Buskens Christianne J., de Groof E. Joline, Eshuis Emma J., Gardenbroek Tjibbe J., Mol Bregje, Stokkers Pieter C. F., Bemelman Willem A., Ponsioen Cyriel Y., Hart Ailsa, Warusavitarne Janindra, van Bodegraven Ad A., Brink Menno A., Consten Esther C. J., van Wagensveld Bart A., Rijk Marno C. M., Crolla Rogier M. P. H., Noomen Casper G., Houdijk Alexander P. J., Mallant Rosalie C., Boom Maarten, Marsman Willem A., Stockmann Hein B., de Groof A. Jeroen, Bruin Karlien, Maring John, van Ditzhuijsen Theo, Prins Hubert, van den Brande Jan, Kingma Paul, van Geloven Anna, de Boer Nanne, van der Peet Donald, Jansen Jeroen, Gerhards Michael, van der Woude Janneke, Schouten Ruud, Oldenburg Bas, van Hillegersberg Richard, West Rachel, Mannaerts Guido, Spanier Marcel, Spillenaar Bilgen Ernst Jan, Lieverse Rob, van der Zaag Edwin, Depla Annekatrien, van de Laar Arnold, Cahen Djuna Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial lancet. Gastroenterology & hepatology 2020;5 (10):900-907 [PubMed]
• Lansdorp Corine A., Buskens Christianne J., Gecse Krisztina B., D’Haens Geert R. A. M., van Hulst Rob A. Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease Alimentary pharmacology & therapeutics 2020;52 (1):215-216 [PubMed]
• Loftus Edward V., Feagan Brian G., Panaccione Remo, Colombel Jean-Frédéric, Sandborn William J., Sands Bruce E., Danese Silvio, D’Haens Geert, Rubin David T., Shafran Ira, Parfionovas Andrejus, Rogers Raquel, Lirio Richard A., Vermeire S. verine Long-term safety of vedolizumab for inflammatory bowel disease Alimentary pharmacology & therapeutics 2020;52 (8):1353-1365 [PubMed]
• Houttuijn Bloemendaal Felicia M. Macrophages as a therapeutic target in inflammatory bowel disease: Lessons learned from anti-TNF therapy 2020. 145p. ISBN 9789402820386. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van den Brink Gijs R., D'Haens Geert R. A. M.; Co-supervisors: Wildenberg Manon E., Koelink Pim J.)
• Rubin David T., Abreu Maria T., Rai Victoria, Siegel Corey A., Ahuja Vineet, Allez Matthieu, Ananthakrishnan Ashwin N., Bernstein Charles N., Braun Jonathan G., Chowers Yehuda, Colombel Jean-Frederic, Danese Silvio, D'Haens Geert, D'Hoore Andre, Dignass Axel, Dotan Iris, Dubinsky Marla C., Ekbom Anders, Fleshner Phillip R., Gassull Miquel A., Gearry Richard B., Ghosh Subrata, Griffiths Anne M., Halfvarson Jonas, Hanauer Stephen B., Harpaz Noam, Hart Ailsa, Kamm Michael A., Kaplan Gil G., Koutroubakis Ioannis, Lakatos Peter L., Levine Arie, Lewis James D., Lindsay James O., Loftus Edward V., Louis Edouard, Lukas Milan, Magro Fernando, Mahadevan Uma, Mantzaris Gerasimos J., McGovern Dermot P., Moum Bjørn A., Munkholm Pia, Neurath Markus F., Ng Siew C., O'Morain Colm, Panaccione Remo, Panes Julian, Peyrin-Biroulet Laurent, Prantera Cosimo Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting Gastroenterology 2020;159 (1):6-13.e6 [PubMed]
• Sands Bruce E., Feagan Brian G., Sandborn William J., Schreiber Stefan, Peyrin-Biroulet Laurent, Colombel Jean Frédéric, Rossiter Guillermo, Usiskin Keith, Ather Shabana, Zhan Xiaojiang, D’Haens Geert Mongersen (GED-0301) for active Crohn’s disease: Results of a phase 3 study American journal of gastroenterology 2020;115 (5):738-745 [PubMed]
• Dreesen Erwin, Baert Filip, Laharie David, Bossuyt Peter, Bouhnik Yoram, Buisson Anthony, Lambrecht Guy, Louis Edouard, Oldenburg Bas, Pariente Benjamin, Pierik Marieke, van der Woude C. Janneke, D'Haens Geert, Vermeire S. verine, Gils Ann Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease Clinical gastroenterology and hepatology 2020;18 (3):637-646.e11 [PubMed]
• Argollo Marjorie, Kotze Paulo Gustavo, Kakkadasam Pradeep, D’Haens Geert Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? Nature reviews. Gastroenterology & hepatology 2020;17 (11):702-710 [PubMed]
• Colombel Jean-Frédéric, D'haens Geert, Lee Wan-Ju, Petersson Joel, Panaccione Remo Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review Journal of Crohn s & colitis 2020;14 (2):254-266 [PubMed]
• Feagan Brian G., Sandborn William J., Danese Silvio, Wolf Douglas C., Liu Wenzhong J., Hua Steven Y., Minton Neil, Olson Allan, D'Haens Geert Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study lancet. Gastroenterology & hepatology 2020;5 (9):819-828 [PubMed]
• Dulai Parambir S., Singh Siddharth, Jairath Vipul, Ma Christopher, Narula Neeraj, Vande Casteele Niels, Peyrin-Biroulet Laurent, Vermeire Severine, D’Haens Geert, Feagan Brian G., Sandborn William J. Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis Alimentary pharmacology & therapeutics 2020;51 (4):435-445 [PubMed]
• Ma Christopher, Gecse Krisztina B., Duijvestein Marjolijn, Sandborn William J., Zou Guangyong, Shackelton Lisa M., Stitt Larry W., Parker Claire E., Bossuyt Peter, Löwenberg Mark, Khanna Reena, Vermeire Severine, Rutgeerts Paul, Feagan Brian G., Jairath Vipul, D'Haens Geert R. Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease Clinical gastroenterology and hepatology 2020;18 (9):2139-2141.e2 [PubMed]
• van Wassenaer Elsa A., van Oosterhout Janneke P. M., Daams Joost G., van den Berg Merlijn J. M., van der Lee Hanneke, D'Haens Geert R., de Meij Tim G. J., Benninga Marc A., Koot Bart G. P. Safety of Rapid Infliximab Infusions in Children: A Systematic Review Journal of pediatric gastroenterology and nutrition 2020;71 (3):361-365 [PubMed]
• Stellingwerf Merle E. Surgery in Inflammatory Bowel Disease: A different point of view 2020. 275p. ISBN 9789463808989. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bemelman Wilhelmus A., D'Haens Geert R. A. M.; Co-supervisor: Buskens Christianne J.)
• Brand Eelco C., Elias Sjoerd G., Minderhoud Itta M., van der Veen Julius J., Baert Filip J., Laharie David, Bossuyt Peter, Bouhnik Yoram, Buisson Anthony, Lambrecht Guy, Louis Edouard, Pariente Benjamin, Pierik Marieke J., van der Woude C. Janneke, D'Haens Geert R. A. M., Vermeire S. verine, Oldenburg Bas Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease Clinical gastroenterology and hepatology 2020;18 (8):1704-1718 [PubMed]
• de Voogd F. A., Mookhoek A., Gecse K. B., de Hertogh G., Bemelman W. A., Buskens C. J., D'Haens G. R. Systematic Review: Histological Scoring of Strictures in Crohn's Disease Journal of Crohn s & colitis 2020;14 (6):734-742 [PubMed]
• Panaccione Remo, Colombel Jean-Frederic, Travis Simon P. L., Bossuyt Peter, Baert Filip, Vanásek Tomáš, Danalloglu Ahmet, Novacek Gottfried, Armuzzi Alessandro, Reinisch Walter, Johnson Scott, Buessing Marric, Neimark Ezequiel, Petersson Joel, Lee Wan-Ju, D'Haens Geert R. Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: An economic assessment of the CALM trial Gut 2020;69 (4):658-664 [PubMed]
• Wasmann Karin A., de Groof E. Joline, Stellingwerf Merel E., D'Haens Geert R., Ponsioen Cyriel Y., Gecse Krisztina B., Dijkgraaf Marcel G. W., Gerhards Michael F., Jansen Jeroen M., Pronk Apollo, van Tuyl Sebastiaan A. C., Zimmerman David D. E., Bruin Karlien F., Spinelli Antonino, Danese Silvio, van der Bilt Jarmila D. W., Mundt Marco W., Bemelman Willem A., Buskens Christianne J. Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial Journal of Crohn s & colitis 2020;14 (8):1049-1056 [PubMed]
• Lansdorp Corine A., Buskens Christianne J., Gecse Krisztina B., D’Haens Geert R. AM, van Hulst Rob A. Wound healing of metastatic perineal Crohn’s disease using hyperbaric oxygen therapy: A case series United European gastroenterology journal 2020;8 (7):820-827 [PubMed]

2019

• Jairath Vipul, Jeyarajah Jenny, Zou Guangyong, Parker Claire E., Olson Allan, Khanna Reena, D'Haens Geert R., Sandborn William J., Feagan Brian G. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score lancet. Gastroenterology & hepatology 2019;4 (1):63-70 [PubMed]
• Loftus Edward V., Reinisch Walter, Panaccione Remo, Berg Sofie, Alperovich Gabriela, Bereswill Mareike, Kalabic Jasmina, Petersson Joel, Thakkar Roopal, Robinson Anne M., D'Haens Geert Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry Inflammatory bowel diseases 2019;25 (9):1522-1531 [PubMed]
• de Vries L. C. S., Duarte J. M., de Krijger M., Welting O., van Hamersveld P. H. P., van Leeuwen-Hilbers F. W. M., Moerland P. D., Jongejan A., D'Haens G. R., de Jonge W. J., Wildenberg M. E. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function Inflammatory bowel diseases 2019;25 (4):647-660 [PubMed]
• Danese Silvio, Hart Ailsa, Dignass Axel, Fiorino Gionata, Louis Edouard, Bonovas Stefanos, D'Haens Geert, Dotan Iris, Rogler Gerhard, Paridaens Kristine, Peyrin-Biroulet Laurent A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis United European gastroenterology journal 2019;7 (9):1171-1182 [PubMed]
• Hanžel Jurij, D’Haens Geert R. Anti-interleukin-23 agents for the treatment of ulcerative colitis Expert opinion on biological therapy 2019:1-8 [PubMed]
• Sahami S., Wildenberg M. E., Koens L., Doherty G., Martin S., D'Haens G. R. A. M., Cullen G., Bemelman W. A., Winter D., Buskens C. J. Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation: Short-Term Results of the PASSION Study Journal of Crohn s & colitis 2019;13 (2):165-171 [PubMed]
• Gecse Krisztina B., Cumming Fraser, D’Haens Geert Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients’ concerns? Expert review of gastroenterology & hepatology 2019;13 (2):143-155 [PubMed]
• van Wassenaer Elsa A., de Voogd Floris A. E., van Rijn Rick R., van der Lee Johanna H., Tabbers Merit M., van Etten-Jamaludin Faridi S., Kindermann Angelika, de Meij Tim G. J., Gecse K. B., D’Haens Geert R., Benninga Marc A., Koot Bart G. P. Bowel ultrasound measurements in healthy children — systematic review and meta-analysis Pediatric radiology 2019 [PubMed]
• Colombel Jean-Frédéric, Adedokun Omoniyi J., Gasink Christopher, Gao Long-Long, Cornillie Freddy J., D'Haens Geert R., Rutgeerts Paul J., Reinisch Walter, Sandborn William J., Hanauer Stephen B. Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Clinical gastroenterology and hepatology 2019;17 (8):1525-1532.e1 [PubMed]
• de groof E. Joline, Stevens Toer W., Eshuis Emma J., Gardenbroek Tjibbe J., Bosmans Judith E., van Dongen J. M., Mol Bregje, Buskens Christianne J., Stokkers Pieter C. F., Hart Ailsa, D'Haens Geert R., Bemelman Willem A., Ponsioen Cyriel Y., Warusavitarne Janindra, van Bodegraven Ad A., Brink Menno A., J Consten Esther C., van Wagensveld Bart A., M Rijk Marno C., P H Crolla Rogier M., Noomen Casper G., J Houdijk Alexander P., Mallant Rosalie C., Boom Maarten, Marsman Willem A., Stockmann Hein B., Bruin Karlien, Maring John, Ditzhuijsen Theo van, Prins Hubert, den Brande Jan van, Kingma Paul, Geloven Anna van, de Boer Nanne, der Peet Donald van, Jansen Jeroen, Gerhards Michael, van der Woude Janneke, Schouten Ruud, Oldenburg Bas, van Hillegersberg Richard, West Rachel, Mannaerts Guido, Spanier Marcel, Spillenaar Bilgen Ernst Jan, Lieverse Rob, der Zaag Edwin van, Depla Annekatrien, de Laar Arnold van, Cahen Djuna Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: The LIR!C Trial Gut 2019;68 (10):1774-1780 [PubMed]
• Samaan Mark A., Forsyth Katrina, Segal Jonathan P., de Jong Djuna, Vleugels Jasper L. A., Elkady Soad, Kabir Misha, Campbell Samantha, Kok Klaartje, Armstrong David G., Penez Lawrence, Arenaza Aitor P., Seward Edward, Vega Roser, Mehta Shameer, Rahman Farooq, McCartney Sara, Bloom Stuart, Patel Kamal, Pollok Richard, Westcott Edward, Darakhshan Amir, Williams Andrew, Koumoutsos Ioannis, Ray Shuvra, Mawdsley Joel, Anderson Simon, Sanderson Jeremy D., Dekker Evelien, D'Haens Geert R., Hart Ailsa, Irving Peter M. Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study Journal of Crohn s & colitis 2019;13 (6):735-743 [PubMed]
• Pai Rish K., Khanna Reena, D'Haens Geert R., Sandborn William J., Jeyarajah Jenny, Feagan Brian G., Vande Casteele Niels, Jairath Vipul Definitions of response and remission for the Robarts Histopathology Index Gut 2019;68 (11):2101-2102 [PubMed]
• Hindryckx Pieter, Jairath Vipul, Zou Guangyong, Feagan Brian G., Sandborn William J., Stoker Jaap, Khanna Reena, Stitt Larry, van Viegen Tanja, Shackelton Lisa M., Taylor Stuart A., Santillan Cynthia, Mearadji Banafsche, D'Haens Geert, Richard Marie-Paule, Panes Julian, Rimola Jordi Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease Gastroenterology 2019;157 (5):1233-1244.e5 [PubMed]
• Vleugels Jasper L. A., Rutter Mathew D., Ragunath Krish, Rees Colin J., Ponsioen Cyriel Y., Lahiff Conor, Ket Shara N., Wanders Linda K., Samuel Sunil, Butt Faheem, Kuiper Taeco, Travis Simon P. L., D'Haens Geert, Wang Lai Mun, van Eeden Susanne, East James E., Dekker Evelien Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis: Correction Journal of Crohn s & colitis 2019;13 (12):1586 [PubMed]
• Stevens Toer W., D'Haens Geert R., Duijvestein Marjolijn, Bemelman Willem A., Buskens Christianne J., Gecse Krisztina B. Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas United European gastroenterology journal 2019;7 (4):496-506 [PubMed]
• van Wassenaer Elsa A., de Voogd Floris A. E., van Rijn Rick R., van der Lee Johanna H., Tabbers Merit M., van Etten-Jamaludin Faridi S., Gecse Krisztina B., Kindermann Angelika, de Meij Tim G. J., D'haens Geert R., Benninga Marc A., Koot Bart G. P. Diagnostic Accuracy of Transabdominal Ultrasound in Detecting Intestinal Inflammation in Paediatric IBD Patients-a Systematic Review Journal of Crohn s & colitis 2019;13 (12):1501-1509 [PubMed]
• Berends Sophie E., D'Haens Geert R. A. M., Schaap Tiny, de Vries Annick, Rispens Theo, Bloem Karien, Mathôt Ron A. A. Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation British journal of clinical pharmacology 2019;85 (7):1544-1551 [PubMed]
• Sandborn William J., Baert Filip, Danese Silvio, Krznarić Željko, Kobayashi Taku, Yao Xiaopan, Chen Jingjing, Rosario Maria, Bhatia Siddharth, Kisfalvi Krisztina, D'Haens Geert, Vermeire S. verine Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis Gastroenterology 2019 [PubMed]
• Bettenworth Dominik, Mücke Marcus M., Lopez Rocio, Singh Amandeep, Zhu Weiming, Guo Feilong, Matsui Toshiyuki, James Theodore W., Herfarth Hans, Goetz Martin, Mao Ren, Kurada Satya, Hampe Jochen, Matthes Katja, Karstensen John G. sdal, Valli Piero V., Duijvestein Marjolijn, D'Haens Geert, Jairath Vipul, Qiu Tian Bai, Ding Nik Sheng, Rogler Gerhard, Rieder Florian Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data Clinical gastroenterology and hepatology 2019;17 (12):2514-2522.e8 [PubMed]
• D'Haens Geert R., Jobin Christian Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection Gastroenterology 2019;157 (3):624-636 [PubMed]
• Strik Anne S., D’Haens Geert R., Löwenberg Mark Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report Clinical case reports 2019 [PubMed]
• Lansdorp C. A., Gecse K. B., Buskens C. J., Land Wenberg M., Stoker J., Bemelman W. A., D'Haens G. R. A. M., van Hulst R. A. Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn's disease (HOT-TOPIC): study protocol of a prospective interventional cohort study with one-year follow-up Undersea & hyperbaric medicine 2019;46 (1):45-53 [PubMed]
• Gecse Krisztina B., D'Haens Geert R. Infliximab biosimilar CT-P13 in Crohn's disease Lancet 2019;393 (10182):1671-1672 [PubMed]
• D'Haens Geert, Pinzani Massimo Intestinal and hepatic fibrosis: how are they similar? lancet. Gastroenterology & hepatology 2019;4 (11):820-822 [PubMed]
• Panés Julián, D’Haens Geert R., Higgins Peter D. R., Mele Linda, Moscariello Michele, Chan Gary, Wang Wenjin, Niezychowski Wojciech, Su Chinyu, Maller Eric Long-term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open-label, 48-week extension study Alimentary pharmacology & therapeutics 2019;49 (3):265-276 [PubMed]
• de Groof E Joline, van der Meer Jonathan H M, Tanis Pieter J, de Bruyn Jessica R, van Ruler Oddeke, D'Haens Geert R A M, van den Brink Gijs R, Bemelman Willem A, Wildenberg Manon E, Buskens Christianne J Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease Journal of Crohn s & colitis 2019;13 (3):285-293 [PubMed]
• Strik Anne S. Personalized treatment with anti-TNF agents in inflammatory bowel disease 2019. 198p. ISBN 9789461829801. [UvA Dissertations Online] University of Amsterdam. (Supervisors: D'Haens G. R. A. M., Mathot Ronald)
• Stellingwerf M. E., Sahami S., Winter D. C., Martin S. T., D'Haens G. R., Cullen G., Doherty G. A., Mulcahy H., Bemelman W. A., Buskens C. J. Prospective cohort study of appendicectomy for treatment of therapy-refractory ulcerative colitis British journal of surgery 2019 [PubMed]
• Duijvestein Marjolijn, D’Haens Geert R. Rational and clinical development of the anti-MAdCAM monoclonal antibody for the treatment of IBD Expert opinion on biological therapy 2019;19 (4):361-366 [PubMed]
• Bots Steven J., Kuin Sabine, Ponsioen Cyriel Y., Gecse Krisztina B., Duijvestein Marjolijn, D’Haens Geert R., Löwenberg Mark Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy Scandinavian journal of gastroenterology 2019;54 (3):281-288 [PubMed]
• Jairath Vipul, Peyrin-Biroulet Laurent, Zou Guangyong, Mosli Mahmoud, Vande Casteele Niels, Pai Reetesh K., Valasek Mark A., Marchal-Bressenot Aude, Stitt Larry W., Shackelton Lisa M., Khanna Reena, D'Haens Geert R., Sandborn William J., Olson Allan, Feagan Brian G., Pai Rish K. Responsiveness of histological disease activity indices in ulcerative colitis: A post hoc analysis using data from the TOUCHSTONE randomised controlled trial Gut 2019;68 (7):1162-1168 [PubMed]
• Sandborn William J., Panés Julián, D'Haens Geert R., Sands Bruce E., Su Chinyu, Moscariello Michele, Jones Thomas, Pedersen Ron, Friedman Gary S., Lawendy Nervin, Chan Gary Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials Clinical gastroenterology and hepatology 2019;17 (8):1541-1550 [PubMed]
• Berends Sophie E., van Steeg Tamara J., Ahsman Maurice J., Singh Sharat, Brandse Johannan F., D’Haens Geert R. A. M., Mathôt Ron A. A. Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients Journal of pharmacokinetics and pharmacodynamics 2019;46 (6):543–551 [PubMed]
• D’Haens Geert R. A. M., Lindsay James O., Panaccione Remo, Schreiber Stefan Ulcerative Colitis: Shifting Sands Drugs in R and D 2019;19 (2):227-234 [PubMed]
• de Jong Djuna C., Löwenberg Mark, Koumoutsos Ioannis, Ray Shuvra, Mawdsley Joel, Anderson Simon, Sanderson Jeremy D., Gecse Krisztina, Ponsioen Cyriel Y., D'Haens Geert R., Irving Peter M., Samaan Mark A. Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity Inflammatory bowel diseases 2019;25 (5):937-944 [PubMed]
• Löwenberg Mark, Vermeire Severine, Mostafavi Nahid, Hoentjen Frank, Franchimont Denis, Bossuyt Peter, Hindryckx Pieter, Rispens Theo, de Vries Annick, van der Woude C. Janneke, Berends Sophie, Ambarus Carmen A., Mathot Ron, Clasquin Esme, Baert Filip, D'Haens Geert Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease Gastroenterology 2019;157 (4):997-1006.e6 [PubMed]

2018

• Li Yim Andrew Y F, de Bruyn Jessica R, Duijvis Nicolette W, Sharp Catriona, Ferrero Enrico, de Jonge Wouter J, Wildenberg Manon E, Mannens Marcel M A M, Buskens Christianne J, D'Haens Geert R, Henneman Peter, Te Velde Anje A A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients PLoS ONE 2018;13 (12):e0209656 [PubMed]
• Ma Christopher, Panaccione Remo, Fedorak Richard N., Parker Claire E., Nguyen Tran M., Khanna Reena, Siegel Corey A., Peyrin-Biroulet Laurent, D'Haens Geert, Sandborn William J., Feagan Brian G., Jairath Vipul A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials Clinical gastroenterology and hepatology 2018;16 (5):637-647.e13 [PubMed]
• Willian Mary Kaye, D’haens Geert, Yarlas Aaron, Joshi Ashish V. Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: A prospective, open-label study Journal of Patient-Reported Outcomes 2018;2 [PubMed]
• Vleugels Jasper L. A., Rutter Matt D., Ragunath Krish, Rees Colin J., Ponsioen Cyriel Y., Lahiff Conor, Ket Shara N., Wanders Linda K., Samuel Sunil, Butt Faheem, Kuiper Teaco, Travis Simon P. L., D'Haens Geert, Wang Lai M., van Eeden Susanne, East James E., Dekker Evelien Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial lancet. Gastroenterology & hepatology 2018;3 (5):305-316 [PubMed]
• Panaccione Remo, Sandborn William J., D'Haens Geert, Wolf Douglas C., Berg Sofie, Maa Jen-Fue, Petersson Joel, Robinson Anne M. Clinical benefit of long-term adalimumab treatment in patients with Crohn's disease following loss of response or intolerance to infliximab: 96-week efficacy data from gain/adhere trials Journal of Crohn s & colitis 2018;12 (8):930-938 [PubMed]
• Colombel Jean-Frédéric, Panaccione Remo, Petersson Joel, Robinson Anne M., D'Haens Geert Clinical disease activity in the CALM study – Authors' reply Lancet 2018;391 (10129):1482 [PubMed]
• Bots Steven, Gecse Krisztina, Barclay Murray, D'Haens Geert Combination immunosuppression in IBD Inflammatory bowel diseases 2018;24 (3):539-545 [PubMed]
• Jairath Vipul, Levesque Barrett G., Casteele Niels Vande, Khanna Reena, Mosli Mahmoud, Hindryckx Pieter, Travis Simon, Duijvestein Marjolijn, Rimola Jordi, Panes Julian, D'Haens Geert, Sandborn William J., Feagana Brian G. Corrigendum: Evolving concepts in phases I and II drug development for Crohn's disease [Journal of Crohn's and Colitis, 631 (2018)] doi:10.1093/ecco-jcc/jjx171 Journal of Crohn s & colitis 2018;12 (5):631-631 [PubMed]
• Siegel Corey A., Whitman Cynthia B., Spiegel Brennan M. R., Feagan Brian, Sands Bruce, Loftus Edward V., Panaccione Remo, D'Haens Geert, Bernstein Charles N., Gearry Richard, Ng Siew C., Mantzaris Gerassimos J., Sartor Balfour, Silverberg Mark S., Riddell Robert, Koutroubakis Ioannis E., O'Morain Colm, Lakatos Peter L., McGovern Dermot P. B., Halfvarson Jonas, Reinisch Walter, Rogler Gerhard, Kruis Wolfgang, Tysk Curt, Schreiber Stefan, Danese Silvio, Sandborn William, Griffiths Anne, Moum Bjorn, Gasche Christoph, Pallone Francesco, Travis Simon, Panes Julian, Colombel Jean-Frederic, Hanauer Stephen, Peyrin-Biroulet Laurent Development of an index to define overall disease severity in IBD Gut 2018;67 (2):244-254 [PubMed]
• Koelink Pim J., Wildenberg Manon E., Stitt Larry W., Feagan Brian G., Koldijk Martin, van 't Wout Angélique B., Atreya Raja, Vieth Michael, Brandse Johannan F., Duijst Suzanne, te Velde Anje A., D'Haens Geert R. A. M., Levesque Barrett G., van den Brink Gijs R. Development of reliable, valid and responsive scoring systems for endoscopy and histology in animal models for inflammatory bowel disease Journal of Crohn s & colitis 2018;12 (7):794-803 [PubMed]
• Vleugels Jasper L. A., Rutter Mathew D., Ragunath Krish, Rees Colin J., Ponsioen Cyriel Y., Lahiff Conor, Ket Shara N., Wanders Linda K., Samuel Sunil, Butt Faheem, Kuiper Taeco, Travis Simon P. L., D'Haens Geert, Wang Lai Mun, van Eeden Susanne, East James E., Dekker Evelien Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis Journal of Crohn s & colitis 2018;12 (12):1438-1447 [PubMed]
• Hindryckx Pieter, Levesque Barrett G., Holvoet Tom, Durand Serina, Tang Ceen-Ming, Parker Claire, Khanna Reena, Shackelton Lisa M., D'Haens Geert, Sandborn William J., Feagan Brian G., Lebwohl Benjamin, Leffler Daniel A., Jairath Vipul Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials Gut 2018;67 (1):61-+ [PubMed]
• Strik Anne S., Dreesen Erwin, Samaan Mark, Gecse Krisztina, Matheeuwsen Mijntje, Berends Sophie, D'Haens Geert Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab Cochrane database of systematic reviews (Online) 2018;2018 (7)
• D'Haens Geert, Vermeire Séverine, Vogelsang Harald, Allez Matthieu, Desreumaux Pierre, van Gossum Andre, Sandborn William J., Baumgart Daniel C., Ransohoff Richard M., Comer Gail M., Ahmad Alaa, Cataldi Fabio, Cheng John, Clare Robert, Gorelick Kenneth J., Kaminski Annamarie, Pradhan Vivek, Rivers Sunday, Sikpi Matthew O., Zhang Yanhua, Hassan-Zahraee Mina, Reinisch Walter, Stuve Olaf Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating beta 7+T Cells in Crohn's Disease: Report of the TOSCA Study Journal of Crohn s & colitis 2018;12 (2):188-196 [PubMed]
• Colombel Jean-Frederic, Panaccione Remo, Bossuyt Peter, Lukas Milan, Baert Filip, Vaňásek Tomas, Danalioglu Ahmet, Novacek Gottfried, Armuzzi Alessandro, Hébuterne Xavier, Travis Simon, Danese Silvio, Reinisch Walter, Sandborn William J., Rutgeerts Paul, Hommes Daniel, Schreiber Stefan, Neimark Ezequiel, Huang Bidan, Zhou Qian, Mendez Paloma, Petersson Joel, Wallace Kori, Robinson Anne M., Thakkar Roopal B., D'Haens Geert Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Lancet 2018;390 (10114):2779-2789 [PubMed]
• Berends Sophie E., Strik Anne S., van Selm Juliet C., Löwenberg Mark, Ponsioen Cyriel Y., D'Haens Geert R., Mathôt Ron A. Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients with Crohn's Disease Therapeutic drug monitoring 2018;40 (2):202-211 [PubMed]
• de Bruyn Jessica R. Fibrosis and vitamin D in inflammatory bowel diseases: IBD considered from both basic and clinical perspectives 2018. ISBN 9789402810417. [UvA Dissertations Online] University of Amsterdam. (Supervisors: D'Haens G. R. A. M., van den Brink G. R.)
• de Bruyn Jessica R., van den Brink Gijs R., Steenkamer Jessica, Buskens Christianne J., Bemelman Willem A., Meisner Sander, Muncan Vanesa, te Velde Anje A., D'Haens Geert R., Wildenberg Manon E. Fibrostenotic phenotype of myofibroblasts in crohn's disease is dependent on tissue stiffness and reversed by LOX inhibition Journal of Crohn s & colitis 2018;12 (7):849-859 [PubMed]
• Yarlas Aaron, D'Haens Geert, Willian Mary Kaye, Teynor Megan Health-Related Quality of Life and Work-Related Outcomes for Patients with Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment with Multimatrix Mesalamine: A Prospective, Open-Label Study Inflammatory bowel diseases 2018;24 (2):450-463 [PubMed]
• Ma Christopher, Hussein Isra M., Al-Abbar Yousef J., Panaccione Remo, Fedorak Richard N., Parker Claire E., Nguyen Tran M., Khanna Reena, Siegel Corey A., Peyrin-Biroulet Laurent, Pai Rish K., Vande Casteele Niels, D'Haens Geert R., Sandborn William J., Feagan Brian G., Jairath Vipul Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review Clinical gastroenterology and hepatology 2018;16 (9):1407-1419.e22 [PubMed]
• Duijvis Nicolette W. IBD therapy redesigned: From established therapeutic regimens to prospective epigenetic approaches 2018. 192p. ISBN 9789402812756. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Jonge W. J., D'Haens G. R. A. M. , Löwenberg M.; Co-supervisor: te Velde A. A.)
• Danese Silvio, Bonovas Stefanos, Lopez Anthony, Fiorino Gionata, Sandborn William J., Rubin David T., Kamm Michael A., Colombel Jean-Frederic, Sands Bruce E., Vermeire Severine, Panes Julian, Rogler Gerhard, D'Haens Geert, Peyrin-Biroulet Laurent Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease Gastroenterology 2018;155 (1):76-87 [PubMed]
• D'Haens Geert, Vermeire Severine, Lambrecht Guy, Baert Filip, Bossuyt Peter, Pariente Benjamin, Buisson Anthony, Bouhnik Yoram, Filippi Jérôme, Vander Woude Janneke, van Hootegem Philippe, Moreau Jacques, Louis Edouard, Franchimont Denis, de Vos Martine, Mana Fazia, Peyrin-Biroulet Laurent, Brixi Hedia, Allez Matthieu, Caenepeel Philip, Aubourg Alexandre, Oldenburg Bas, Pierik Marieke, Gils Ann, Chevret Sylvie, Laharie David Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease Gastroenterology 2018;154 (5):1343-1351.e1 [PubMed]
• de Bruyn Jessica R., Becker Marte A., Steenkamer Jessica, Wildenberg Manon E., Meijer Sybren L., Buskens Christianne J., Bemelman Willem A., Löwenberg Mark, Ponsioen Cyriel Y., van den Brink Gijs R., D'Haens Geert R. Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease PLoS ONE 2018;13 (1):e0190999 [PubMed]
• Strik A. S., D'Haens G. R. Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply Alimentary pharmacology & therapeutics 2018;47 (7):1041-1042 [PubMed]
• Hoekman Daniël R., Stibbe Judith A., Baert Filip J., Caenepeel Philip, Vergauwe Philippe, de Vos Martine, Hommes Daniel W., Benninga Marc A., Vermeire Severine A., D'Haens Geert R. Long-Term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease Journal of Crohn s & colitis 2018;12 (5):517-524 [PubMed]
• D'Haens Geert, Reinisch Walter, Panaccione Remo, Satsangi Jack, Petersson Joel, Bereswill Mareike, Arikan Dilek, Perotti Eva, Robinson Anne M., Kalabic Jasmina, Alperovich Gabriela, Thakkar Roopal, Loftus Edward V. Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry American journal of gastroenterology 2018;113 (6):872-882 [PubMed]
• Levin Alon D. Mechanism of action of anti-TNF therapy in Inflammatory bowel disease: Towards improving efficacy of anti-TNF therapy 2018. 159p. ISBN 9789402809015. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van den Brink G. R., D'Haens G. R. A. M.; Co-supervisor: Wildenberg M. E.)
• Duijvestein Marjolijn, Battat Robert, Vande Casteele Niels, D'Haens Geert R., Sandborn William J., Khanna Reena, Jairath Vipul, Feagan Brian G. Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease Current treatment options in gastroenterology 2018;16 (1):129-146 [PubMed]
• Sandborn William J., Lee Scott D., Tarabar Dino, Louis Edouard, Klopocka Maria, Klaus Jochen, Reinisch Walter, Hébuterne Xavier, Park Dong-Il, Schreiber Stefan, Nayak Satyaprakash, Ahmad Alaa, Banerjee Anindita, Brown Lisa S., Cataldi Fabio, Gorelick Kenneth J., Cheng John B., Hassan-Zahraee Mina, Clare Robert, D'Haens Geert R. Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study Gut 2018;67:1824-1835 [PubMed]
• Olivera P., Sandborn W. J., Panés J., Baumann C., D'Haens G., Vermeire S., Danese S., Peyrin-Biroulet L. Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey Alimentary pharmacology & therapeutics 2018;47 (6):773-783 [PubMed]
• Samaan Mark A., Shen Bo, Mosli Mahmoud H., Zou Guangyong, Sandborn William J., Shackelton Lisa M., Nelson Sigrid, Stitt Larry, Bloom Stuart, Pardi Darrell S., Gionchetti Paolo, Lindsay James, Travis Simon, Hart Ailsa, Silverberg Mark S., Feagan Brian G., D'Haens Geert R., Jairath Vipul Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis Gastrointestinal endoscopy 2018;88 (2):360-369.e2 [PubMed]
• Warners M. J., Ambarus C. A., Bredenoord A. J., Verheij J., Lauwers G. Y., Walsh J. C., Katzka D. A., Nelson S., van Viegen T., Furuta G. T., Gupta S. K., Stitt L., Zou G., Parker C. E., Shackelton L. M., D'Haens G. R., Sandborn W. J., Dellon E. S., Feagan B. G., Collins M. H., Jairath V., Pai R. K. Reliability of histologic assessment in patients with eosinophilic oesophagitis Alimentary pharmacology & therapeutics 2018;47 (7):940-950 [PubMed]
• Jairath Vipul, Ordas Ingrid, Zou Guangyong, Panes Julian, Stoker Jaap, Taylor Stuart A., Santillan Cynthia, Horsthuis Karin, Samaan Mark A., Shackelton Lisa M., Stitt Larry W., Hindryckx Pieter, Khanna Reena, Sandborn William J., D'Haens Geert, Feagan Brian G., Levesque Barrett G., Rimola Jordi Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography Inflammatory bowel diseases 2018;24 (2):440-449 [PubMed]
• D'Haens Geert, Vermeire Severine, Laharie David Reply Gastroenterology 2018;155 (4):1278-1279 [PubMed]
• Feagan Brian G., Panés Julián, Ferrante Marc, Kaser Arthur, D'Haens Geert R., Sandborn William J., Louis Edouard, Neurath Markus F., Franchimont Denis, Dewit Olivier, Seidler Ursula, Kim Kyung-Jo, Selinger Christian, Padula Steven J., Herichova Ivona, Robinson Anne M., Wallace Kori, Zhao Jun, Minocha Mukul, Othman Ahmed A., Soaita Adina, Visvanathan Sudha, Hall David B., Böcher Wulf O. Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study lancet. Gastroenterology & hepatology 2018;3 (10):671-680
• Strik Anne S., van de Vrie Wim, Bloemsaat-Minekus Joanne P. J., Nurmohamed Michael, Bossuyt Peter J. J., Bodelier Alexander, Rispens Theo, van Megen Yvonne J. B., D'Haens Geert R. Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial lancet. Gastroenterology & hepatology 2018;3 (6):404-412 [PubMed]
• Rowan C. R., Keegan D., Byrne K., Cullen G., Mulcahy H. E., Sheridan J., Ryan E. J., de Vries A., D'Haens G., Doherty G. A. Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study Alimentary pharmacology & therapeutics 2018;48 (3):333-339 [PubMed]
• Ma C., Guizzetti L., Panaccione R., Fedorak R. N., Pai R. K., Parker C. E., Nguyen T. M., Khanna R., Vande Casteele N., D'Haens G., Sandborn W. J., Feagan B. G., Jairath V. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis Alimentary pharmacology & therapeutics 2018;47 (12):1578-1596 [PubMed]
• Hindryckx Pieter, Vande Casteele Niels, Novak Gregor, Khanna Reena, D'Haens Geert, Sandborn William J., Danese Silvio, Jairath Vipul, Feagan Brian G. The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients? Journal of Crohn s & colitis 2018;12 (1):105-119 [PubMed]
• van Gennep Sara, de Boer Nanne K., D'Haens Geert R., Löwenberg Mark Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice Inflammatory bowel diseases 2018;24 (1):67-77 [PubMed]
• Bloemendaal Felicia M., Koelink Pim J., van Schie Karin A., Rispens Theo, Peters Charlotte P., Buskens Christianne J., van der Bilt Jarmila D., Bemelman Willem A., Korf Hannelie, Sabino João G., Ponsioen Cyriel Y., te Velde Anje A., D'Haens Geert R. A. M., Vermeire Severine, van den Brink Gijs R., Wildenberg Manon E. TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an fc-dependent mechanism Journal of Crohn s & colitis 2018;12 (9):1122-1130 [PubMed]

2017

• Bloemendaal Felicia M., Levin Alon D., Wildenberg Manon E., Koelink Pim J., Mcrae Bradford L., Salfeld Jochen, Lum Jenifer, van der Neut Kolfschoten Marijn, Claassens Jill W., Visser Remco, Bentlage Arthur, D'Haens Geert R. A. M., Verbeek J. Sjef, Vidarsson Gestur, van den Brink Gijs R. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis Gastroenterology 2017;153 (5):1351-1362.e4 [PubMed]
• Brandse Johannan F., Mould Diane, Smeekes Oscar, Ashruf Yaël, Kuin Sabine, Strik Anne, van den Brink Gijs R., Dʼhaens Geert R. A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease Inflammatory bowel diseases 2017;23 (4):650-660 [PubMed]
• Wildenberg Manon E., Levin Alon D., Ceroni Alessandro, Guo Zhen, Koelink Pim J., Hakvoort Theodorus B. M., Westera Liset, Bloemendaal Felicia M., Brandse Johannan F., Simmons Alison, D'Haens Geert R., Ebner Daniel, van den Brink Gijs R. Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and Enhance Therapeutic Efficacy in a Murine Model Journal of Crohn s & colitis 2017;11 (12):1480-1490 [PubMed]
• Westera Liset, van Viegen Tanja, Jeyarajah Jenny, Azad Azar, Bilsborough Janine, van den Brink Gijs R., Cremer Jonathan, Danese Silvio, D'Haens Geert, Eckmann Lars, Faubion William, Filice Melissa, Korf Hannelie, McGovern Dermot, Panes Julian, Salas Azucena, Sandborn William J., Silverberg Mark S., Smith Michelle I., Vermeire Severine, Vetrano Stefania, Shackelton Lisa M., Stitt Larry, Jairath Vipul, Levesque Barrett G., Spencer David M., Feagan Brian G., Vande Casteele Niels Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study Clinical and translational gastroenterology 2017;8 (11):e126 [PubMed]
• Reinisch Walter, Colombel Jean-Frédéric, D'Haens Geert, Sandborn William J., Rutgeerts Paul, Geboes Karel, Petersson Joel, Eichner Samantha, Zhou Qian, Robinson Anne M., Read Holly A., Thakkar Roopal Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial Journal of Crohn s & colitis 2017;11 (4):425-434 [PubMed]
• Spekhorst Lieke M., Imhann Floris, Festen Eleonora A. M., van Bodegraven Ad A., de Boer Nanne K. H., Bouma Gerd, Fidder Herma H., D'Haens Geert, Hoentjen Frank, Hommes Daan W., de Jong Dirk J., Löwenberg Mark, Maljaars P. W. Jeroen, van der Meulen-de Jong Andrea E., Oldenburg Bas, Pierik Marieke J., Ponsioen Cyriel Y., Stokkers Pieter C., Verspaget Hein W., Visschedijk Marijn C., van der Woude C. Janneke, Dijkstra Gerard, Weersma Rinse K. Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease BMJ open 2017;7 (11):e016695 [PubMed]
• van Gennep Sara, Sahami Saloomeh, Buskens Christianne J., van den Brink Gijs R., Ponsioen Cyriel Y., D'Hoore André, de Buck van Overstraeten Anthony, van Assche Gert, Ferrante Marc, Vermeire Séverine, Bemelman Willem A., D'Haens Geert R. A. M., Löwenberg Mark Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy European journal of gastroenterology & hepatology 2017;29 (3):338-344 [PubMed]
• Khanna Reena, Zou GuangYong, Stitt Larry, Feagan Brian G., Sandborn William J., Rutgeerts Paul, McDonald John W. D., Dubcenco Elena, Fogel Ronald, Panaccione Remo, Jairath Vipul, Nelson Sigrid, Shackelton Lisa M., Huang Bidan, Zhou Qian, Robinson Anne M., Levesque Barrett G., D'Haens Geert Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease American journal of gastroenterology 2017;112 (6):975 [PubMed]
• Mosli Mahmoud H., Feagan Brian G., Zou Guangyong, Sandborn William J., D'Haens Geert, Khanna Reena, Shackelton Lisa M., Walker Christopher W., Nelson Sigrid, Vandervoort Margaret K., Frisbie Valerie, Samaan Mark A., Jairath Vipul, Driman David K., Geboes Karel, Valasek Mark A., Pai Rish K., Lauwers Gregory Y., Riddell Robert, Stitt Larry W., Levesque Barrett G. Development and validation of a histological index for UC Gut 2017;66 (1):50-58 [PubMed]
• Strik A. S., D'Haens G. R. Editorial: anti-tumour necrosis factor α antibodies - can efficacy be regained? Authors' reply Alimentary pharmacology & therapeutics 2017;45 (11):1474-1475 [PubMed]
• Simon M., Cosnes J., Gornet J. M., Seksik P., Stefanescu C., Blain A., Pariente B., Nancey S., Vuitton L., Nachury M., D'Haens G., Filippi J., Chevret S., Laharie D. Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients Journal of Crohn s & colitis 2017;11 (1):47-52 [PubMed]
• Jairath Vipul, Levesque Barrett G., Vande Casteele Niels, Khanna Reena, Mosli Mahmoud, Hindryckx Pieter, Travis Simon, Duijvenstein Marjolejn, Rimola Jordi, Panes Julian, D'Haens Geert, Sandborn William J., Feagan Brian G. Evolving Concepts in Phases I and II Drug Development for Crohn's Disease Journal of Crohn s & colitis 2017;11 (2):246-255 [PubMed]
• D'Haens Geert, Reinisch Walter, Colombel Jean-Frederic, Panes Julian, Ghosh Subrata, Prantera Cosimo, Lindgren Stefan, Hommes Daniel W., Huang Zhiping, Boice Judith, Huyck Susan, Cornillie Freddy Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade (R)] or Conventional Therapy Journal of Crohn s & colitis 2017;11 (6):680-689 [PubMed]
• Strik Anne S., Berends Sophie E., Mathôt Ron A., D'Haens Geert R., Löwenberg Mark Golimumab for moderate to severe ulcerative colitis Expert review of gastroenterology & hepatology 2017;11 (5):401-406 [PubMed]
• de Vries Leonie C. S., Ludbrook Valerie J., Hicks Kirsty J., D'Haens Geert R. GSK2586184, a JAK1 selective inhibitor, in two patients with ulcerative colitis BMJ case reports 2017;2017 [PubMed]
• Novak Gregor, Parker Claire E., Pai Rish K., Macdonald John K., Feagan Brian G., Sandborn William J., D'Haens Geert, Jairath Vipul, Khanna Reena Histologic scoring indices for evaluation of disease activity in Crohn's disease Cochrane database of systematic reviews (Online) 2017;2017 (7):CD012351 [PubMed]
• Feagan Brian G., Sandborn William J., D'Haens Geert, Panés Julián, Kaser Arthur, Ferrante Marc, Louis Edouard, Franchimont Denis, Dewit Olivier, Seidler Ursula, Kim Kyung-Jo, Neurath Markus F., Schreiber Stefan, Scholl Paul, Pamulapati Chandrasena, Lalovic Bojan, Visvanathan Sudha, Padula Steven J., Herichova Ivona, Soaita Adina, Hall David B., Böcher Wulf O. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study Lancet 2017;389 (10080):1699-1709 [PubMed]
• van Schie Karin A., Ooijevaar-de Heer Pleuni, Kruithof Simone, Plasencia Chamaida, Jurado Teresa, Pascual Salcedo Dora, Brandse Johannan F., D'Haens Geert Ram, Wolbink Gerrit Jan, Rispens Theo Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies Annals of the rheumatic diseases 2017;76 (7):1285-1288 [PubMed]
• Ponsioen Cyriel Y., de Groof E. Joline, Eshuis Emma J., Gardenbroek Tjibbe J., Bossuyt Patrick M. M., Hart Ailsa, Warusavitarne Janindra, Buskens Christianne J., van Bodegraven Ad A., Brink Menno A., Consten Esther C. J., van Wagensveld Bart A., Rijk Marno C. M., Crolla Rogier M. P. H., Noomen Casper G., Houdijk Alexander P. J., Mallant Rosalie C., Boom Maarten, Marsman Willem A., Stockmann Hein B., Mol Bregje, de Groof A. Jeroen, Stokkers Pieter C., D'Haens Geert R., Bemelman Willem A., Bruin Karlien F., Maring John K., van Ditzhuijsen Theo J., Prins Hubert A., van den Brande Jan M., Kingma Paul J., van Geloven Anna A., de Boer Nanne H., van der Peet Donald L., Jansen Jeroen M., Gerhards Michael F., van der Woude C. Janneke, Schouten W. Ruud, Oldenburg Bas, van Hillegersberg Richard, West Rachel L., Mannaerts Guido H., Spanier Marcel, Bilgen Ernst Jan Spillenaar, Lieverse Rob J., van der Zaag Edwin S., Depla Annekatrien, van de Laar Arnold W., Bolwerk Clemens J., Cahen Djuna L. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial lancet. Gastroenterology & hepatology 2017;2 (11):785-792 [PubMed]
• Vermeire Severine, Loftus Edward V., Colombel Jean-Frédéric, Feagan Brian G., Sandborn William J., Sands Bruce E., Danese Silvio, D'Haens Geert R., Kaser Arthur, Panaccione Remo, Rubin David T., Shafran Ira, McAuliffe Megan, Kaviya Arpeat, Sankoh Serap, Mody Reema, Abhyankar Brihad, Smyth Michael Long-term Efficacy of Vedolizumab for Crohn's Disease Journal of Crohn s & colitis 2017;11 (4):412-424 [PubMed]
• Loftus Edward V., Colombel Jean-Frédéric, Feagan Brian G., Vermeire Severine, Sandborn William J., Sands Bruce E., Danese Silvio, D'Haens Geert R., Kaser Arthur, Panaccione Remo, Rubin David T., Shafran Ira, McAuliffe Megan, Kaviya Arpeat, Sankoh Serap, Mody Reema, Abhyankar Brihad, Smyth Michael Long-term Efficacy of Vedolizumab for Ulcerative Colitis Journal of Crohn s & colitis 2017;11 (4):400-411 [PubMed]
• Fuentes Susana, Rossen Noortje G., van der Spek Mirjam J., Hartman Jorn Ha, Huuskonen Laura, Korpela Katri, Salojärvi Jarkko, Aalvink Steven, de Vos Willem M., D'Haens Geert R., Zoetendal Erwin G., Ponsioen Cyriel Y. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation ISME journal 2017;11 (8):1877-1889 [PubMed]
• Sahami Saloomeh New concepts in ulcerative colitis: A thin line between medicine and surgery 2017. 244p. ISBN 9789462336230. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Bemelman W. A.; Co-supervisors: D'Haens G. R. A. M., van den Brink G. R., Buskens C. J.)
• Sahami S., Buskens C. J., van den Brink G. R., D'Haens G. R., Bemelman W. A. Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis Reply American journal of gastroenterology 2017;112 (1):184-185 [PubMed]
• Bots S. J. A., Hoekman D. R., Benninga M. A., Ponsioen C. Y., D'Haens G. R., Löwenberg M. Patterns of anti-TNF use and associated treatment outcomes in inflammatory bowel disease patients: results from an analysis of Dutch health insurance claims data Netherlands journal of medicine 2017;75 (10):432-442 [PubMed]
• Jairath Vipul, Zou G. Y., Parker Claire E., Macdonald John K., AlAmeel Turki, Al Beshir Mohammad, Almadi Majid A., Al-Taweel Talal, Atkinson Nathan S. S., Biswas Sujata, Chapman Thomas, Dulai Parambir S., Glaire Mark A., Hoekman Daniel R., Koutsoumpas Andreas, Minas Elizabeth, Mosli Mahmoud H., Samaan Mark, Khanna Reena, Travis Simon, D'Haens Geert, Sandborn William J., Feagan Brian G. Placebo response and remission rates in randomised trials of induction andmaintenance therapy for ulcerative colitis Cochrane database of systematic reviews (Online) 2017;2017 (9):CD011572 [PubMed]
• Spekhorst Lieke M., Oldenburg Bas, van Bodegraven Ad A., de Jong Dirk J., Imhann Floris, van der Meulen-de Jong Andrea E., Pierik Marieke J., van der Woude Janneke C., Dijkstra Gerard, D'Haens Geert, Löwenberg Mark, Weersma Rinse K., Festen Eleonora A. M. Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease World journal of gastroenterology 2017;23 (46):8182-8192 [PubMed]
• Doorenspleet M. E., Westera L., Peters C. P., Hakvoort T. B. M., Esveldt R. E., Vogels E., van Kampen A. H. C., Baas F., Buskens C., Bemelman W. A., D'Haens G., Ponsioen C. Y., te Velde A. A., de Vries N. [=Niek], van den Brink G. R. Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease Journal of Crohn s & colitis 2017;11 (7):831-839 [PubMed]
• D'Haens G. R., Sandborn W. J., Zou G., Stitt L. W., Rutgeerts P. J., Gilgen D., Jairath V., Hindryckx P., Shackelton L. M., Vandervoort M. K., Parker C. E., Muller C., Pai R. K., Levchenko O., Marakhouski Y., Horynski M., Mikhailova E., Kharchenko N., Pimanov S., Feagan B. G. Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis Alimentary pharmacology & therapeutics 2017;46 (3):292-302 [PubMed]
• Khanna Reena, Zou Guangyong, Stitt Larry, Feagan Brian G., Sandborn William J., Rutgeerts Paul, McDonald John W. D., Dubcenco Elena, Fogel Ronald, Panaccione Remo, Jairath Vipul, Nelson Sigrid, Shackelton Lisa M., Huang Bidan, Zhou Qian, Robinson Anne M., Levesque Barrett G., D'Haens Geert Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease American journal of gastroenterology 2017;112 (10):1584-1592 [PubMed]
• Hindryckx P., Novak G., Vande Casteele N., Laukens D., Parker C., Shackelton L. M., Narula N., Khanna R., Dulai P., Levesque B. G., Sandborn W. J., D'Haens G., Feagan B. G., Jairath V. Review article: dose optimisation of infliximab for acute severe ulcerative colitis Alimentary pharmacology & therapeutics 2017;45 (5):617-630 [PubMed]
• Sahami S., Konté K., Buskens C. J., Tanis P. J., Löwenberg M., Ponsioen C. J., van den Brink G. R., Bemelman W. A., D'Haens G. R. Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis United European gastroenterology journal 2017;5 (4):554-562 [PubMed]
• de Buck van Overstraeten A., Eshuis E. J., Vermeire S., van Assche G., Ferrante M., D'Haens G. R., Ponsioen C. Y., Belmans A., Buskens C. J., Wolthuis A. M., Bemelman W. A., D'Hoore A. Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres British journal of surgery 2017;104 (12):1713-1722 [PubMed]
• Strik A. S., van den Brink G. R., Ponsioen C., Mathot R., Löwenberg M., D'Haens G. R. Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease Alimentary pharmacology & therapeutics 2017;45 (8):1128-1134 [PubMed]
• de Groof Elisabeth J. Surgery and medical therapy in Crohn's disease: improving treatment strategies 2017. 327p. ISBN 9789462336018. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bemelman W. A., D'Haens G. R. A. M.; Co-supervisors: Buskens C. J., Ponsioen C. I. J.)
• Warners Marijn J., Hindryckx Pieter, Levesque Barrett G., Parker Claire E., Shackelton Lisa M., Khanna Reena, Sandborn William J., D'Haens Geert R., Feagan Brian G., Bredenoord Albert J., Jairath Vipul Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis American journal of gastroenterology 2017;112 (11):1658-1669 [PubMed]
• de Groof E. J., Gardenbroek T. J., Buskens C. J., Tanis P. J., Ponsioen C. Y., D'Haens G. R. A. M., Bemelman W. A. The association between intensified medical treatment, time to surgery and ileocolic specimen length in Crohn's disease Colorectal disease 2017;19 (6):551-558 [PubMed]
• Wildenberg M. E., Koelink P. J., Diederen K., te Velde A. A., Wolfkamp S. C. S., Nuij V. J., Peppelenbosch M. P., Nobis M., Sansom O. J., Anderson K. I., van der Woude C. J., D'Haens G. R. A. M., van den Brink G. R. The ATG16L1 risk allele associated with Crohn's disease results in a Rac1-dependent defect in dendritic cell migration that is corrected by thiopurines Mucosal immunology 2017;10 (2):352-360 [PubMed]
• Samaan M. A., Puylaert C. A. J., Levesque B. G., Zou G. Y., Stitt L., Taylor S. A., Shackelton L. M., Vandervoort M. K., Khanna R., Santillan C., Rimola J., Hindryckx P., Nio C. Y., Sandborn W. J., D'Haens G., Feagan B. G., Jairath V., Stoker J. The development of a magnetic resonance imaging index for fistulising Crohn's disease Alimentary pharmacology & therapeutics 2017;46 (5):516-528 [PubMed]
• de Vries Leonie, Wildenberg Manon, de Jonge Wouter, D'Haens Geert The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease Journal of Crohn s & colitis 2017;11 (7):885-893 [PubMed]
• Hoekman Daniël R., Zeevenhooven Judith, D'Haens Geert R., Benninga Marc A. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission European journal of gastroenterology & hepatology 2017;29 (9):1086-1090 [PubMed]
• Colombel Jean-Frédéric, Sands Bruce E., Rutgeerts Paul, Sandborn William, Danese Silvio, D'Haens Geert, Panaccione Remo, Loftus Edward V., Sankoh Serap, Fox Irving, Parikh Asit, Milch Catherine, Abhyankar Brihad, Feagan Brian G. The safety of vedolizumab for ulcerative colitis and Crohn's disease Gut 2017;66 (5):839-851 [PubMed]
• Sandborn William J., Su Chinyu, Sands Bruce E., D'Haens Geert R., Vermeire Séverine, Schreiber Stefan, Danese Silvio, Feagan Brian G., Reinisch Walter, Niezychowski Wojciech, Friedman Gary, Lawendy Nervin, Yu Dahong, Woodworth Deborah, Mukherjee Arnab, Zhang Haiying, Healey Paul, Panés Julian Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis New England journal of medicine 2017;376 (18):1723-1736 [PubMed]
• Panés Julian, Sandborn William J., Schreiber Stefan, Sands Bruce E., Vermeire Séverine, D'Haens Geert, Panaccione Remo, Higgins Peter D. R., Colombel Jean-Frederic, Feagan Brian G., Chan Gary, Moscariello Michele, Wang Wenjin, Niezychowski Wojciech, Marren Amy, Healey Paul, Maller Eric Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials Gut 2017;66 (6):1049-1059 [PubMed]

2016

• Hindryckx Pieter, Jairath Vipul, D'Haens Geert Acute severe ulcerative colitis: from pathophysiology to clinical management Nature reviews. Gastroenterology & hepatology 2016;13 (11):654-664 [PubMed]
• Rutgeerts Paul, Reinisch Walter, Colombel Jean-Frederic, Sandborn William J., D'Haens Geert, Petersson Joel, Zhou Qian, Iezzi Annalisa, Thakkar Roopal B. Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial Gastrointestinal endoscopy 2016;83 (1):188-97.e1-3 [PubMed]
• Levin Alon D., Koelink Pim J., Bloemendaal Felicia M., Vos Anne Christine W., D'Haens Geert R., van den Brink Gijs R., Wildenberg Manon E. Autophagy Contributes to the Induction of Anti-TNF Induced Macrophages Journal of Crohn s & colitis 2016;10 (3):323-329 [PubMed]
• de Groof E. Joline, Rossen Noortje G. M., van Rhijn Bram D., Karregat Evert P. M., Boonstra Kirsten, Hageman Ishtu, Bennebroek Evertsz Floor, Kingma Paul J., Naber Anton H. J., van den Brande Jan H. M., Mallant-Hent Rosalie C., Mundt Marco W., D'Haens Geert R. A. M., Ponsioen Cyriel Y. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands European journal of gastroenterology & hepatology 2016;28 (9):1065-1072 [PubMed]
• Hoekman Daniël R., Roelofs Joris J. T. H., van Schuppen Joost, Schonenberg-Meinema Dieneke, D'Haens Geert R., Benninga Marc A. Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn's disease Clinical journal of gastroenterology 2016;9 (2):73-78 [PubMed]
• Mould D. R., D'Haens G., Upton R. N. Clinical Decision Support Tools: The Evolution of a Revolution Clinical pharmacology and therapeutics 2016;99 (4):405-418 [PubMed]
• Danese Silvio, Hart Ailsa, Dignass Axel, Louis Edouard, D'Haens Geert, Dotan Iris, Rogler Gerhard, D'Agay Laurence, Iannacone Claudio, Peyrin-Biroulet Laurent Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study BMJ open gastroenterology 2016;3 (1):e000092 [PubMed]
• Khanna Reena, Jairath Vipul, Vande Casteele Niels, Mosli Mahmoud H., Zou Guangyong, Parker Claire E., Levesque Barrett G., Sandborn William J., D'Haens Geert, Feagan Brian G. Efficient Early Drug Development for Ulcerative Colitis Gastroenterology 2016;150 (5):1056-1060 [PubMed]
• Khanna Reena, Nelson Sigrid A., Feagan Brian G., D'Haens Geert, Sandborn William J., Zou G. Y., Macdonald John K., Parker Claire E., Jairath Vipul, Levesque Barrett G. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease Cochrane database of systematic reviews (Online) 2016;2016 (8):CD010642 [PubMed]
• Gardenbroek Tjibbe J., Pinkney Thomas D., Sahami Saloomeh, Morton Dion G., Buskens Christianne J., Ponsioen Cyriel Y., Tanis Pieter J., Löwenberg Mark, van den Brink Gijs R., Broeders Ivo A. M. J., Pullens Hendrikus J. M., Seerden Tom, Boom Maarten J., Mallant-Hent Rosalie C., Pierik Robert E. G. J. M., Vecht Juda, Sosef Meindert N., van Nunen Annick B., van Wagensveld Bart A., Stokkers Pieter C. F., Gerhards Michael F., Jansen Jeroen M., Acherman Yair, Depla Annekatrien C. T. M., Mannaerts Guido H. H., West Rachel, Iqbal Tariq, Pathmakanthan Shrikanth, Howard Rebecca, Magill Laura, Singh Baljit, Oo Ye H., Negpodiev Dmitri, Dijkgraaf Marcel G. W., D'Haens Geert R. A. M., Bemelman Willem A. Erratum to: The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019) BMC surgery 2016;16 (1):1 [PubMed]
• Mcrae Bradford L., Levin Alon D., Wildenberg Manon E., Koelink Pim J., Bousquet Peter, Mikaelian Igor, Sterman Annette Schwartz, Bryant Shaughn, D'Haens Geert, Kamath Rajesh, Salfeld Jochen, van den Brink Gijs R. Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease Journal of Crohn s & colitis 2016;10 (1):69-76 [PubMed]
• Samaan Mark A., de Jong Djuna, Sahami Saloomeh, Morgan Samantha, Fragkos Konstantinos, Subramaniam Sharmila, Kok Klaartje, Makanyanga Jesica, Barnova Ivana, Saravanapavan Hajeena, Parisi Ioanna, Di Caro Simona, Vega Roser, Rahman Farooq, McCartney Sara, Bloom Stuart L., van den Brink Gijs R., Löwenberg Mark, Ponsioen Cyriel Y., Buskens Christianne J., Tanis Pieter J., de Buck van Overstraeten Anthony, DʼHoore Andre, Bemelman Willem A., Dʼhaens Geert R. Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis? Inflammatory bowel diseases 2016;22 (3):662-668 [PubMed]
• Regueiro Miguel, Feagan Brian G., Zou Bin, Johanns Jewel, Blank Marion A., Chevrier Marc, Plevy Scott, Popp John, Cornillie Freddy J., Lukas Milan, Danese Silvio, Gionchetti Paolo, Hanauer Stephen B., Reinisch Walter, Sandborn William J., Sorrentino Dario, Rutgeerts Paul, Debinski H., Florin T., Hetzel D., Lawrance I., Radford-Smith G., Sloss A., Sorrentino D., Gassner S., Haas T., Reicht G., Reinisch W., Strasser M., Vogelsang H., Bossuyt P., Dewit O., D'Haens G., Franchimont D., Louis E., Vermeire S., Bernstein C. N., Bourdages R., Chiba N., Dhalla S. S., Feagan B. G., Fedorak R. N., Lachance J. R., Panaccione R., Ropeleski M., Singh Salh B., Lukas M., Colombel J.-F., Allez M., Schultz M. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection Gastroenterology 2016;150 (7):1568-1578 [PubMed]
• Vuitton L., Marteau P., Sandborn W. J., Levesque B. G., Feagan B., Vermeire S., Danese S., D'Haens G., Lowenberg M., Khanna R., Fiorino G., Travis S., Mary J. Y., Peyrin-Biroulet L. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials Gut 2016;65 (9):1447-1455 [PubMed]
• Ghosh Subrata, D'Haens Geert Is an Ounce of Prevention Worth a Pound of Cure: Postoperative Recurrence of Crohn's Disease? Gastroenterology 2016;150 (7):1521-1524 [PubMed]
• Strik A. S., Bots S. J. A., D'Haens G., Löwenberg M. Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease Expert review of clinical pharmacology 2016;9 (3):429-439 [PubMed]
• Sandborn William J., Feagan Brian G., Wolf Douglas C., D'Haens Geert, Vermeire Severine, Hanauer Stephen B., Ghosh Subrata, Smith Heather, Cravets Matthew, Frohna Paul A., Aranda Richard, Gujrathi Sheila, Olson Allan, Sparrow Miles, Vermeire Séverine, Churchev Jordan, Kotzev Iskren, Takov Dimitar, Dragomirov Borislav, Vladimirov Borislav, Stoynov Simeon, Krastev Zahariy, Yordanova Liliana, Tchernev Konstantin, Feagan Brian, Karamanolis Dimitrios, Tsianos Epameinondas, Potamianos Spyridon, Schnabel Róbert, Kiss Gyula G., Gyökeres Tibor, Taller András, Rachmilewitz Daniel, Goldin Eran, Avni Yona, Oren Ran, Konikoff Fred, Segol Ori, Delgado Jorge-Shmuel, Jang Byung Ik, Kim Hyo Jong, Kim Hyun Soo, Park Sang Hyoung, Cheon Jae Hee, Park Dong Il, Jung Sung Ae, Huh Kyu Chan, Lee Kang Moon, Lowenberg Marc, Wolfhagen Frank Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis New England journal of medicine 2016;374 (18):1754-1762 [PubMed]
• Brandse Johannan F., Bennink Roel J., van Eeden Susanne, Löwenberg Mark, van den Brink Gijs R., Dʼhaens Geert R. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis Inflammatory bowel diseases 2016;22 (6):1384-1390 [PubMed]
• Li Yim Andrew Y. F., Duijvis Nicolette W., Zhao Jing, de Jonge Wouter J., D'Haens Geert R. A. M., Mannens Marcel M. A. M., Mul Adri N. P. M., te Velde Anje A., Henneman Peter Peripheral blood methylation profiling of female Crohn's disease patients Clinical epigenetics 2016;8:65 [PubMed]
• Brandse Johannan F., Mathôt Ron A., van der Kleij Desiree, Rispens Theo, Ashruf Yaël, Jansen Jeroen M., Rietdijk Svend, Löwenberg Mark, Ponsioen Cyriel Y., Singh Sharat, van den Brink Gijs R., D'Haens Geert R. Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis Clinical gastroenterology and hepatology 2016;14 (2):251-8.e1-2 [PubMed]
• Khanna Reena, Zou Guangyong, D'Haens Geert, Rutgeerts Paul, McDonald J. W. D., Daperno Marco, Feagan Brian G., Sandborn William J., Dubcenco Elena, Stitt Larry, Vandervoort Margaret K., Donner Allan, Luo Allison, Levesque Barrett G. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease Gut 2016;65 (7):1119-1125 [PubMed]
• Kuin Sabine, Stolte Suzan B., van den Brink Gijs R., Ponsioen Cyriel Y., Fockens Paul, D'Haens Geert R., Löwenberg Mark Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease European journal of gastroenterology & hepatology 2016;28 (2):222-225 [PubMed]
• Duijvis Nicolette W., ten Hove Anne S., Ponsioen Cyriel I. J., van den Brink Gijs R., Buskens Christianne J., Bemelman Willem A., te Velde Anje A., D'Haens Geert R. A. M., Löwenberg Mark Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients Journal of Crohn s & colitis 2016;10 (7):821-827 [PubMed]
• D'Haens Geert Standardisation of Study Protocols - Pros and Cons Journal of Crohn s & colitis 2016;10 (Suppl. 2):S553-S559 [PubMed]
• Hoekman Daniël R. Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults 2016. 310p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Benninga M. A., D'Haens G. R. A. M.; Co-supervisors: Löwenberg M., Vlieger A. M.)
• Jairath Vipul, Zou Guangyong, Parker Claire E., Macdonald John K., Mosli Mahmoud H., Khanna Reena, Shackelton Lisa M., Vandervoort Margaret K., AlAmeel Turki, Al Beshir Mohammad, AlMadi Majid, Al-Taweel Talal, Atkinson Nathan S. S., Biswas Sujata, Chapman Thomas P., Dulai Parambir S., Glaire Mark A., Hoekman Daniel, Koutsoumpas Andreas, Minas Elizabeth, Samaan Mark A., Travis Simon, D'Haens Geert, Levesque Barrett G., Sandborn William J., Feagan Brian G. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis Journal of Crohn s & colitis 2016;10 (5):607-618 [PubMed]
• D'Haens G. Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis Alimentary pharmacology & therapeutics 2016;44 (10):1018-1029 [PubMed]
• D'Haens Geert, Bressler Brian, Danese Silvio, Gibson Peter, Hanauer Stephen B., Sandborn William The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Clinical gastroenterology and hepatology 2016;14 (4):638-639 [PubMed]
• Sandborn William, Colombel Jean-Frédéric, D'Haens Geert, Ghosh Subrata, Panaccione Remo, Panés Julian, Travis Simon, Peyrin-Biroulet Laurent The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice Clinical gastroenterology and hepatology 2016;14 (9):e121-e122 [PubMed]
• Rossen Noortje G. M. The microbiome and its therapeutic potential in inflammatory bowel diseases 2016. 208p. ISBN 9789461697905. [UvA Dissertations Online] University of Amsterdam. (Supervisor: D'Haens G. R. A. M.; Co-supervisors: Ponsioen C. Y., Zoetendal E. G.)
• Rubin David T., Bradette Marc, Gabalec Libor, Dobru Daniela, Márquez Juan, Inglis Susi, Magee Elizabeth, Solomon Dory, D'Haens Geert Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Journal of Crohn s & colitis 2016;10 (8):925-933 [PubMed]
• Dujardin Romein W. G., Meijer Berrie, de Boer Nanne K. H., D'Haens Geert R., Löwenberg Mark Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease European journal of gastroenterology & hepatology 2016;28 (9):991-996 [PubMed]

2015

• van Cutsem E., Prenen H., D'Haens G., Bennouna J., Carrato A., Ducreux M., Bouché O., Sobrero A., Latini L., Staines H., Oum'Hamed Z., Dressler H., Studeny M., Capdevila J. A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients Annals of oncology 2015;26 (10):2085-2091 [PubMed]
• D'Haens Geert, Sandborn William J., Colombel Jean Frederic, Rutgeerts Paul, Brown Kurt, Barkay Hadas, Sakov Anat, Haviv Asi, Feagan Brian G., Vermeire Severine, Baert Filip, Dupas Jean-Louis, Bouhnik Yoram, Bonaz Bruno, Hebuterne Xavier, Allez Matthieu, Israeli Eran, Fraser Gerald, Segol Ori, Fishman Sigal, Lahat Adi, Melzer Ehud, Pallone Francesco, Campieri Massimo, Gasbarrini Antonio, Kohn Anna, Vecchi Maurizo, Ponsioen Cyriel, van der Woude Janneke, Rydzewska Grazyna, Mach Tomasz, Paradowski Leszek, Wright John Philip, Watermeyer Gillian Ann, Pettengell Keith Edward, Mahomed Adam Dawood, Prins Maarten Jeroen, Aboo Nazimuddin, Diaz Julian Panes, Taxonera Carlos, Gisbert Javier, Hinojosa Joaquin, Garcia Fernand Gomollon, Sanchez Valle Garcia, Parkes Miles, Probert Chris, Leiper Keith, Nwokolo Chuka, Mayberry John, Bloom Stuart A phase II study of laquinimod in Crohn's disease Gut 2015;64 (8):1227-1235 [PubMed]
• Khanna R., Zou G., D'Haens G., Feagan B. G., Sandborn W. J., Vandervoort M. K., Rolleri R. L., Bortey E., Paterson C., Forbes W. P., Levesque B. G. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity Alimentary pharmacology & therapeutics 2015;41 (1):77-86 [PubMed]
• Dulai Parambir S., Levesque Barrett G., Feagan Brian G., D'Haens Geert, Sandborn William J. Assessment of mucosal healing in inflammatory bowel disease: review Gastrointestinal endoscopy 2015;82 (2):246-255 [PubMed]
• Lichtenstein Gary R., Travis Simon, Danese Silvio, D'Haens Geert, Moro Luigi, Jones Richard, Huang Michael, Ballard E. David, Bagin Robert, Hardiman Yun, Collazo Raul, Sandborn William J. Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis Journal of Crohn s & colitis 2015;9 (9):738-746 [PubMed]
• Bouguen Guillaume, Sninsky Charles, Tang Kezhen L., Colombel Jean-Frederic, Dʼhaens Geert, Kornbluth Asher, Mantzaris Gerassimos J., Rachmilewitz Daniel, Reinisch Walter, Rutgeerts Paul, Molenda Mark, Jannekevan der Woude C., Sandborn William J. Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC Inflammatory bowel diseases 2015;21 (3):606-614 [PubMed]
• de Bruyn Jessica R., Meijer Sybren L., Wildenberg Manon E., Bemelman Willem A., van den Brink Gijs R., D'Haens Geert R. Development of Fibrosis in Acute and Longstanding Ulcerative Colitis Journal of Crohn s & colitis 2015;9 (11):966-972 [PubMed]
• Jairath V., Khanna R., Zou G. Y., Stitt L., Mosli M., Vandervoort M. K., D'Haens G., Sandborn W. J., Feagan B. G., Levesque B. G. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials Alimentary pharmacology & therapeutics 2015;42 (10):1200-1210 [PubMed]
• Danese Silvio, Fiorino Gionata, Mary Jean-Yves, Lakatos Peter L., D'Haens Geert, Moja Lorenzo, D'Hoore André, Panes Julian, Reinisch Walter, Sandborn William J., Travis Simon P., Vermeire Séverine, Peyrin-Biroulet Laurent, Colombel Jean-Fréderic Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative Journal of Crohn s & colitis 2015;9 (8):601-606 [PubMed]
• Pariente Benjamin, Mary Jean-Yves, Danese Silvio, Chowers Yehuda, de Cruz Peter, D'Haens Geert, Loftus Edward V., Louis Edouard, Panés Julian, Schölmerich Jürgen, Schreiber Stefan, Vecchi Maurizio, Branche Julien, Bruining David, Fiorino Gionata, Herzog Matthias, Kamm Michael A., Klein Amir, Lewin Maïté, Meunier Paul, Ordas Ingrid, Strauch Ulrike, Tontini Gian-Eugenio, Zagdanski Anne-Marie, Bonifacio Cristiana, Rimola Jordi, Nachury Maria, Leroy Christophe, Sandborn William, Colombel Jean-Frédéric, Cosnes Jacques Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease Gastroenterology 2015;148 (1):52-63.e3 [PubMed]
• Khanna Reena, Bressler Brian, Levesque Barrett G., Zou Guangyong, Stitt Larry W., Greenberg Gordon R., Panaccione Remo, Bitton Alain, Paré Pierre, Vermeire Séverine, D'Haens Geert, MacIntosh Donald, Sandborn William J., Donner Allan, Vandervoort Margaret K., Morris Joan C., Feagan Brian G., Anderson Frank, Atkinson Kenneth, Bacchus Rahman, Berezny Gary, Borthistle Bruce, Buckley Alan, Chiba Naoki, Cockeram Alan, Elkashab Magdy, Fashir Baroudi, Gray James, Hemphill Douglas, Hoare Connie, Holland Stephen, Hurowitz Eric, Kaal Nuri, Laflamme Pierre, Borromee Saint-Charles, Lau Helena, McMullen William, Memiche Reshat, Menon Krishna, Miller D. Alexander, O'Hara William, Oravec Michael, Penner Robert, Petrunia Denis, Pluta Henryk, Prabhu Umesh, Prest Marcia, Shaaban Hani, Sheppard Duane, Shulman Scott Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial Lancet 2015;386 (10006):1825-1834 [PubMed]
• Gardenbroek T. J., Musters G. D., Buskens C. J., Ponsioen C. Y., D'Haens G. R. A. M., Dijkgraaf M. G. W., Tanis P. J., Bemelman W. A. Early reconstruction of the leaking ileal pouch-anal anastomosis: a novel solution to an old problem Colorectal disease 2015;17 (5):426-432 [PubMed]
• Rossen Noortje G., Macdonald John K., de Vries Elisabeth M., D'Haens Geert R., de Vos Willem M., Zoetendal Erwin G., Ponsioen Cyriel Y. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review World journal of gastroenterology 2015;21 (17):5359-5371 [PubMed]
• Rossen Noortje G., Fuentes Susana, van der Spek Mirjam J., Tijssen Jan G., Hartman Jorn H. A., Duflou Ann, Löwenberg Mark, van den Brink Gijs R., Mathus-Vliegen Elisabeth M. H., de Vos Willem M., Zoetendal Erwin G., D'Haens Geert R., Ponsioen Cyriel Y. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis Gastroenterology 2015;149 (1):110-118.e4 [PubMed]
• Gecse Krisztina B., Brandse Johannan F., van Wilpe Sandra, Löwenberg Mark, Ponsioen Cyriel, van den Brink Gijs, D'Haens Geert Impact of disease location on fecal calprotectin levels in Crohn's disease Scandinavian journal of gastroenterology 2015;50 (7):841-847 [PubMed]
• Sandborn W. J., Danese S., D'Haens G., Moro L., Jones R., Bagin R., Huang M., Ballard E. David, Masure J., Travis S. Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies Alimentary pharmacology & therapeutics 2015;41 (5):409-418 [PubMed]
• Brandse Johannan F., van den Brink Gijs R., Wildenberg Manon E., van der Kleij Desiree, Rispens Theo, Jansen Jeroen M., Mathôt Ron A., Ponsioen Cyriel Y., Löwenberg Mark, D'Haens Geert R. A. M. Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis Gastroenterology 2015;149 (2):350-5.e2 [PubMed]
• Wanders Linda K., Mooiweer Erik, Wang Junfeng, Bisschops Raf, Offerhaus G. Johan, Siersema Peter D., D'Haens Geert R., Oldenburg Bas, Dekker Evelien Low interobserver agreement among endoscopists in differentiating dysplastic from non-dysplastic lesions during inflammatory bowel disease colitis surveillance Scandinavian journal of gastroenterology 2015;50 (8):1011-1017 [PubMed]
• Rossen N. G., Bart A., Verhaar N., van Nood E., Kootte R., de Groot P. F., D'Haens G. R., Ponsioen C. Y., van Gool T. Low prevalence of Blastocystis sp. in active ulcerative colitis patients European journal of clinical microbiology & infectious diseases 2015;34 (5):1039-1044 [PubMed]
• Dulai Parambir S., Singh Siddharth, Cesarini Monica, Bouguen Guillaume, Nelson Sigrid A., Peyrin-Biroulet Laurent, Feagan Brian G., Ordas Ingrid, Sandborn William J., Santillan Cynthia, Rimola Jordi, Panes Julian, D'Haens Geert, Zou Gy, Stoker Jaap, Macdonald John K., Levesque Barrett G. MRI scoring indices for evaluation of disease activity and severity in Crohn's disease Cochrane database of systematic reviews (Online) 2015;2015 (4)
• de Groof E. Joline, Buskens Christianne J., Ponsioen Cyriel Y., Dijkgraaf Marcel G. W., D'Haens Geert R. A. M., Srivastava Nidhi, van Acker Gijs J. D., Jansen Jeroen M., Gerhards Michael F., Dijkstra Gerard, Lange Johan F. M., Witteman Ben J. M., Kruyt Philip M., Pronk Apollo, van Tuyl Sebastiaan A. C., Bodelier Alexander, Crolla Rogier M. P. H., West Rachel L., Vrijland Wietske W., Consten Esther C. J., Brink Menno A., Tuynman Jurriaan B., de Boer Nanne K. H., Breukink Stephanie O., Pierik Marieke J., Oldenburg Bas, van der Meulen Andrea E., Bonsing Bert A., Spinelli Antonino, Danese Silvio, Sacchi Matteo, Warusavitarne Janindra, Hart Ailsa, Yassin Nuha A., Kennelly Rory P., Cullen Garret J., Winter Desmond C., Hawthorne A. Barney, Torkington Jared, Bemelman Willem A. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial Trials 2015;16 (1):366 [PubMed]
• Löwenberg Mark, D'Haens Geert Next-Generation Therapeutics for IBD Current gastroenterology reports 2015;17 (6):21 [PubMed]
• Brandse Johannan F. Optimizing anti-TNF therapy in inflammatory bowel disease 2015. 195p. ISBN 9789462599437. [UvA Dissertations Online] University of Amsterdam. (Supervisors: D'Haens G. R. A. M., van den Brink G. R.)
• Jairath Vipul, Zou G. Y., Parker Claire E., Macdonald John K., AlAmeel Turki, Al Beshir Mohammad, Almadi Majid A., Al-Taweel Talal, Atkinson Nathan S. S., Biswas Sujata, Chapman Thomas, Dulai Parambir S., Glaire Mark A., Hoekman Daniel R., Koutsoumpas Andreas, Minas Elizabeth, Mosli Mahmoud H., Samaan Mark, Vandervoort Margaret K., Travis Simon, D'Haens Geert, Levesque Barrett G., Sandborn William J., Feagan Brian G. Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitis Cochrane database of systematic reviews (Online) 2015;2015 (3):CD011572
• Zand Aria, van Deen Welmoed K., Inserra Elizabeth K., Hall Laurin, Kane Ellen, Centeno Adriana, Choi Jennifer M., Ha Christina Y., Esrailian Eric, Dʼhaens Geert R., Hommes Daniel W. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact Inflammatory bowel diseases 2015;21 (7):1623-1630 [PubMed]
• Macken E., Vannoote J., Moreels T., Peeters M., Wouters K., D'Haens G. Quality assessment of colonoscopy in Flanders : a voluntary survey among Flemish gastroenterologist Acta gastro-enterologica Belgica 2015;78 (1):18-25 [PubMed]
• Jharap B., Sandborn W. J., Reinisch W., D'Haens G., Robinson A. M., Wang W., Huang B., Lazar A., Thakkar R. B., Colombel J.-F. Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis Alimentary pharmacology & therapeutics 2015;42 (9):1082-1092 [PubMed]
• Feagan B. G., Sandborn W. J., D'Haens G., Lee S. D., Allez M., Fedorak R. N., Seidler U., Vermeire S., Lawrance I. C., Maroney A. C., Jurgensen C. H., Heath A., Chang D. J. Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease Alimentary pharmacology & therapeutics 2015;42 (10):1170-1181 [PubMed]
• Brandse Johannan Frank, D'Haens Geert R. Reply Gastroenterology 2015;149 (7):1989-1990 [PubMed]
• Mosli Mahmoud H., Feagan Brian G., Zou Guangyong, Sandborn William J., D'Haens Geert, Khanna Reena, Behling Cynthia, Kaplan Keith, Driman David K., Shackelton Lisa M., Baker Kenneth A., Macdonald John K., Vandervoort Margaret K., Samaan Mark A., Geboes Karel, Valasek Mark A., Pai Rish, Langner Cord, Riddell Robert, Harpaz Noam, Sewitch Maida, Peterson Michael, Stitt Larry W., Levesque Barrett G. Reproducibility of histological assessments of disease activity in UC Gut 2015;64 (11):1765-1773 [PubMed]
• Papamichael K., van Stappen T., Jairath V., Gecse K., Khanna R., D'Haens G., Vermeire S., Gils A., Feagan B. G., Levesque B. G., Vande Casteele N. Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases Alimentary pharmacology & therapeutics 2015;42 (10):1158-1169 [PubMed]
• D'Haens Geert, Löwenberg Mark, Samaan Mark A., Franchimont Denis, Ponsioen Cyriel, van den Brink Gijs R., Fockens Paul, Bossuyt Peter, Amininejad Leila, Rajamannar Gopalan, Lensink Elsemieke M., van Gossum Andre M. Safety and Feasibility of Using the Second-Generation Pillcam Colon Capsule to Assess Active Colonic Crohn's Disease Clinical gastroenterology and hepatology 2015;13 (8):1480-6.e3 [PubMed]
• Peyrin-Biroulet L., Sandborn W., Sands B. E., Reinisch W., Bemelman W., Bryant R. V., D'Haens G., Dotan I., Dubinsky M., Feagan B., Fiorino G., Gearry R., Krishnareddy S., Lakatos P. L., Loftus E. V., Marteau P., Munkholm P., Murdoch T. B., Ordás I., Panaccione R., Riddell R. H., Ruel J., Rubin D. T., Samaan M., Siegel C. A., Silverberg M. S., Stoker J., Schreiber S., Travis S., van Assche G., Danese S., Panes J., Bouguen G., O'Donnell S., Pariente B., Winer S., Hanauer S., Colombel J.-F. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target American journal of gastroenterology 2015;110 (9):1324-1338 [PubMed]
• Brandse Johannan F., Vos Laura M. C., Jansen Jeroen, Schakel Toos, Ponsioen Cyriel I. J., van den Brink Gijs R., D'Haens Geert R., Löwenberg Mark Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment Journal of Crohn s & colitis 2015;9 (11):973-981 [PubMed]
• Büller Nikè V. J. A., Rosekrans Sanne L., Metcalfe Ciara, Heijmans Jarom, van Dop Willemijn A., Fessler Evelyn, Jansen Marnix, Ahn Christina, Vermeulen Jacqueline L. M., Westendorp B. Florien, Robanus-Maandag Els C., Offerhaus G. Johan, Medema Jan Paul, D'Haens Geert R. A. M., Wildenberg Manon E., de Sauvage Frederic J., Muncan Vanesa, van den Brink Gijs R. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice Gastroenterology 2015;148 (1):170-180.e6 [PubMed]
• Gardenbroek Tjibbe J., Pinkney Thomas D., Sahami Saloomeh, Morton Dion G., Buskens Christianne J., Ponsioen Cyriel Y., Tanis Pieter J., Löwenberg Mark, van den Brink Gijs R., Broeders Ivo A. M. J., Pullens Hendrikus J. M., Pullens Paul H. J. M., Seerden Tom, Boom Maarten J., Mallant-Hent Rosalie C., Pierik Robert E. G. J. M., Vecht Juda, Sosef Meindert N., van Nunen Annick B., van Wagensveld Bart A., Stokkers Pieter C. F., Gerhards Michael F., Jansen Jeroen M., Acherman Yair, Depla Annekatrien C. T. M., Mannaerts Guido H. H., West Rachel, Iqbal Tariq, Pathmakanthan Shrikanth, Howard Rebecca, Magill Laura, Singh Baljit, Oo Ye H., Htun Oo Ye, Negpodiev Dmitri, Dijkgraaf Marcel G. W., D'Haens Geert R. A. M., Bemelman Willem A. The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019) BMC surgery 2015;15 (1):30 [PubMed]
• Hoekman Daniël R., Brandse Johannan F., de Meij Tim G., Hummel Thalia Z., Löwenberg Mark, Benninga Marc A., D'Haens Geert R., Kindermann Angelika The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease Scandinavian journal of gastroenterology 2015;50 (9):1110-1117 [PubMed]
• Rossen Noortje G., Fuentes Susana, Boonstra Kirsten, D'Haens Geert R., Heilig Hans G., Zoetendal Erwin G., de Vos Willem M., Ponsioen Cyriel Y. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II Journal of Crohn s & colitis 2015;9 (4):342-348 [PubMed]

2014

• Peters Charlotte P., Eshuis Emma J., Toxopeüs Florien M., Hellemons Merel E., Jansen Jeroen M., D'Haens Geert R. A. M., Fockens Paul, Stokkers Pieter C. F., Tuynman Hans A. R. E., van Bodegraven Adriaan A., Ponsioen Cyriel Y. Adalimumab for Crohn's disease: long-term sustained benefit in a population-based cohort of 438 patients Journal of Crohn s & colitis 2014;8 (8):866-875 [PubMed]
• Gecse Krisztina B., Bemelman Willem, Kamm Michael A., Stoker Jaap, Khanna Reena, Ng Siew C., Panés Julián, van Assche Gert, Liu Zhanju, Hart Ailsa, Levesque Barrett G., D'Haens Geert, Bouguen Guillaume, Sturm Andreas, Laharie David, Feagan Brian, Sandborn William, Sands Bruce, Colombel Jean-Frederic A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease Gut 2014;63 (9):1381-1392 [PubMed]
• Samaan Mark A., Bagi Preet, Vande Casteele Niels, D'Haens Geert R., Levesque Barrett G. An update on anti-TNF agents in ulcerative colitis Gastroenterology clinics of North America 2014;43 (3):479-494 [PubMed]
• Mojtahed Amirkaveh, Khanna Reena, Sandborn William J., D'Haens Geert R., Feagan Brian G., Shackelton Lisa M., Baker Kenneth A., Dubcenco Elena, Valasek Mark A., Geboes Karel, Levesque Barrett G. Assessment of histologic disease activity in Crohn's disease: a systematic review Inflammatory bowel diseases 2014;20 (11):2092-2103 [PubMed]
• Colombel Jean-Frédéric, Sandborn William J., Allez Matthieu, Dupas Jean-Louis, Dewit Olivier, D'Haens Geert, Bouhnik Yoram, Parker Gerald, Pierre-Louis Bosny, Hébuterne Xavier Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease Clinical gastroenterology and hepatology 2014;12 (3):423-31.e1 [PubMed]
• Khanna Reena, Bouguen Guillaume, Feagan Brian G., Dʼhaens Geert, Sandborn William J., Dubcenco Elena, Baker K. Adam, Levesque Barrett G. A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohn's Disease: Recommendations for Clinical Trial Design Inflammatory bowel diseases 2014;20 (10):1850-1861 [PubMed]
• Samaan Mark A., Mosli Mahmoud H., Sandborn William J., Feagan Brian G., Dʼhaens Geert R., Dubcenco Elena, Baker Kenneth A., Levesque Barrett G. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research Inflammatory bowel diseases 2014;20 (8):1465-1471 [PubMed]
• Wielenga Mattheus C. B., van Lidth de Jeude Jooske F., Rosekrans Sanne L., Levin Alon D., Schukking Monique, D'Haens Geert R. A. M., Heijmans Jarom, Jansen Marnix, Muncan Vanesa, van den Brink Gijs R. Azathioprine does not reduce adenoma formation in a mouse model of sporadic intestinal tumorigenesis World journal of gastroenterology 2014;20 (44):16683-16689 [PubMed]
• Labaere Delphine, Smismans Annick, van Olmen August, Christiaens Paul, D'Haens Geert, Moons Veerle, Cuyle Pieter-Jan, Frans Johan, Bossuyt Peter Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease United European gastroenterology journal 2014;2 (1):30-37 [PubMed]
• Brandse Johannan F., Peters Charlotte P., Gecse Krisztina B., Eshuis Emma J., Jansen Jeroen M., Tuynman Hans A., Löwenberg Mark, Ponsioen Cyriel Y., van den Brink Gijs R., Dʼhaens Geert R. Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease Inflammatory bowel diseases 2014;20 (2):251-258 [PubMed]
• Sands Bruce E., Feagan Brian G., Rutgeerts Paul, Colombel Jean-Frédéric, Sandborn William J., Sy Richmond, D'Haens Geert, Ben-Horin Shomron, Xu Jing, Rosario Maria, Fox Irving, Parikh Asit, Milch Catherine, Hanauer Stephen Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed Gastroenterology 2014;147 (3):618-627.e3 [PubMed]
• Wolf D., D'Haens G., Sandborn W. J., Colombel J.-F., van Assche G., Robinson A. M., Lazar A., Zhou Q., Petersson J., Thakkar R. B. Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis Alimentary pharmacology & therapeutics 2014;40 (5):486-497 [PubMed]
• D'Haens Geert R., Sartor R. Balfour, Silverberg Mark S., Petersson Joel, Rutgeerts Paul Future directions in inflammatory bowel disease management Journal of Crohn s & colitis 2014;8 (8):726-734 [PubMed]
• Meijs Simone, Gardenbroek Tjibbe J., Sprangers Mirjam A. G., Bemelman Willem A., Buskens Christianne J., D'Haens Geert R. A. M., Löwenberg Mark Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents Journal of Crohn s & colitis 2014;8 (7):686-692 [PubMed]
• Mosli Mahmoud H., Feagan Brian G., Sandborn William J., Dʼhaens Geert, Behling Cynthia, Kaplan Keith, Driman David K., Shackelton Lisa M., Baker Kenneth A., Macdonald John K., Vandervoort Margaret K., Geboes Karel, Levesque Barrett G. Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices Inflammatory bowel diseases 2014;20 (3):564-575 [PubMed]
• Löwenberg Mark, Duijvis Nicolette W., Ponsioen Cyriel, van den Brink Gijs R., Fockens Paul, D'Haens Geert R. A. M. Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis European journal of gastroenterology & hepatology 2014;26 (11):1240-1246 [PubMed]
• Heijmans Jarom, Wielenga Mattheus C. B., Rosekrans Sanne Liesbeth, van Lidth de Jeude Jooske F., Roelofs Joris, Groothuis Patrick, Ederveen Antwan, de Jonge-Muller Eveline S. M., Biemond Izak, Hardwick James C. H., D'Haens Geert, Hommes Daniel W., Muncan Vanesa, van den Brink Gijs R. Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer Gut 2014;63 (2):310-316 [PubMed]
• Travis Simon P. L., Danese Silvio, Kupcinskas Limas, Alexeeva Olga, D'Haens Geert, Gibson Peter R., Moro Luigi, Jones Richard, Ballard E. David, Masure Johan, Rossini Matteo, Sandborn William J. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study Gut 2014;63 (3):433-441 [PubMed]
• Papay Pavol, Ignjatovic Ana, Karmiris Konstantinos, Amarante Heda, Miheller Pal, Feagan Brian, D'Haens Geert, Marteau Philippe, Reinisch Walter, Sturm Andreas, Steinwurz Flavio, Egan Laurence, Panes Julian, Edouard Louis, Colombel Jean-Frederic, Panaccione Remo Optimising monitoring in the management of Crohn's disease: A physician perspective (vol 7, pg 653, 2013) Journal of Crohn s & colitis 2014;8 (5):441
• de Bruyn Jessica R., D'Haens Geert R. Response to a letter commenting on "vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in The Netherlands" Journal of Crohn s & colitis 2014;8 (11):1559-1560 [PubMed]
• Gardenbroek Tjibbe Jorrit Surgery for inflammatory bowel disease, crossing borders 2014. 205p. ISBN 9789461695659. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bemelman W. A., D'Haens G. R. A. M.; Co-supervisors: Ponsioen C. Y., Buskens C. J.)
• Rietdijk Svend T., D'Haens Geert R. Vedolizumab for the treatment of ulcerative colitis Expert review of clinical pharmacology 2014;7 (4):423-430 [PubMed]
• de Bruyn Jessica R., van Heeckeren Rosanne, Ponsioen Cyriel Y., van den Brink Gijs R., Löwenberg Mark, Bredenoord Albert J., Frijstein Gerard, D'Haens Geert R. Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands Journal of Crohn s & colitis 2014;8 (10):1267-1273 [PubMed]

2013

• Baert Filip, Glorieus Elien, Reenaers Cathérine, D'Haens Geert, Peeters Harald, Franchimont Dennis, Dewit Olivier, Caenepeel Philippe, Louis Edouard, van Assche Gert, D'Heygere F., George C., van Hootegem P., Ilegems S., Fontaine F., Colard A., Schoofs N., Belaiche J., Louis E., Reenaers C., van Kemseke C., Coche J. C., Dewit O., Rahier J. F., de Reuck M., Baert F., Decaestecker J., de Wulf D., Amininejad L., Franchimont D., van Gossum A., Du Ville L., Hendrickx K., Lepoutre L., Vandervoort J., van der Spek P., Sprengers D., van de Mierop F., Potvin P., Bontems P., Moreels T., van Outryve M., Mana F., de Looze D., de Vos M., Peeters H., Ferrante M., Rutgeerts P., van Assche G., Vermeire S. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients Journal of Crohn s & colitis 2013;7 (2):154-160 [PubMed]
• Panaccione R., Colombel J.-F., Sandborn W. J., D'Haens G., Zhou Q., Pollack P. F., Thakkar R. B., Robinson A. M. Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE Alimentary pharmacology & therapeutics 2013;38 (10):1236-1247 [PubMed]
• Sandborn W. J., Colombel J.-F., D'Haens G., Plevy S. E., Panés J., Robinson A. M., Pollack P. F., Zhou Q., Castillo M., Thakkar R. B. Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease Current medical research and opinion 2013;29 (5):483-493 [PubMed]
• Gecse Krisztina B., Khanna Reena, van den Brink Gijs R., Ponsioen Cyriel Y., Löwenberg Mark, Jairath Vipul, Travis Simon P. L., Sandborn William J., Feagan Brian G., D'Haens Geert R. A. M. Biosimilars in IBD: hope or expectation? Gut 2013;62 (6):803-807 [PubMed]
• Cunningham D., Wong R. P. W., D'Haens G., Douillard J.-Y., Robertson J., Stone A. M., van Cutsem E. Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer British journal of cancer 2013;108 (3):493-502 [PubMed]
• de Vos Martine, Louis Edouard J., Jahnsen Jørgen, Vandervoort Jo G. P., Noman Maja, Dewit Olivier, Dʼhaens Geert R., Franchimont Denis, Baert Filip J., Torp Roald A., Henriksen Magne, Potvin Philippe M. R., van Hootegem Philippe P., Hindryckx Pieter M., Moreels Tom G., Collard Arnaud, Karlsen Lars Normann, Kittang Eirik, Lambrecht Guy, Grimstad Tore, Koch Jonas, Lygren Idar, Coche Jean-Claude R. J., Mana Fazia, van Gossum André, Belaiche Jacques, Cool Mike R., Fontaine Fernand, Maisin Jean-Marc G., Muls Vinciane, Neuville Bart, Staessen Dirk A. J., van Assche Gert A., de Lange Thomas, Solberg Inger Camilla, Vander Cruyssen Bert J. K., Vermeire Severine A. R. A. Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy Inflammatory bowel diseases 2013;19 (10):2111-2117 [PubMed]
• Hébuterne Xavier, Lémann Marc, Bouhnik Yoram, Dewit Olivier, Dupas Jean-Louis, Mross Michael, D'Haens Geert, Mitchev Krassimir, Ernault Étienne, Vermeire Séverine, Brixi-Benmansour Hedia, Moreels Tom G., Mary Jean-Yves, Marteau Philippe, Colombel Jean-Frédéric Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Gut 2013;62 (2):201-208 [PubMed]
• D'Haens Geert, Vermeire Severine Fecal Calprotectin Does Not Predict Endoscopic Remission in Inflammatory Bowel Disease Reply Inflammatory bowel diseases 2013;19 (6):E81 [PubMed]
• Gecse Krisztina, Khanna Reena, Stoker Jaap, Jenkins John T., Gabe Simon, Hahnloser Dieter, D'Haens Geert Fistulizing Crohn's disease: Diagnosis and management United European gastroenterology journal 2013;1 (3):206-213 [PubMed]
• van Lent Anja U., D'Haens Geert R. Management of postoperative recurrence of Crohn's disease Digestive diseases (Basel, Switzerland) 2013;31 (2):222-228 [PubMed]
• Löwenberg Mark, D'Haens Geert Novel targets for inflammatory bowel disease therapeutics Current gastroenterology reports 2013;15 (2):311 [PubMed]
• Sandborn W. J., Colombel J.-F., D'Haens G., van Assche G., Wolf D., Kron M., Lazar A., Robinson A. M., Yang M., Chao J. D., Thakkar R. One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2 Alimentary pharmacology & therapeutics 2013;37 (2):204-213 [PubMed]
• Papay Pavol, Ignjatovic Ana, Karmiris Konstantinos, Amarante Heda, Milheller Pal, Feagan Brian, D'Haens Geert, Marteau Philippe, Reinisch Walter, Sturm Andreas, Steinwurz Flavio, Egan Laurence, Panés Julián, Louis Edouard, Colombel Jean-Frédéric, Panaccione Remo Optimising monitoring in the management of Crohn's disease: A physician's perspective Journal of Crohn s & colitis 2013;7 (8):653-669 [PubMed]
• Bartels S. A. L., Gardenbroek T. J., Bos L., Ponsioen C. Y., D'Haens G. R. A. M., Tanis P. J., Buskens C. J., Bemelman W. A. Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis Colorectal disease 2013;15 (11):1392-1398 [PubMed]
• Rietdijk Svend T., D'Haens Geert R. Recent developments in the treatment of inflammatory bowel disease Journal of digestive diseases 2013;14 (6):282-287 [PubMed]
• Tielbeek Jeroen A. W., Löwenberg Mark, Bipat Shandra, Horsthuis Karin, Ponsioen Cyriel Y., D'Haens Geert R., Stoker Jaap Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease Inflammatory bowel diseases 2013;19 (9):1943-1950 [PubMed]
• Gardenbroek Tjibbe J., Verlaan Tessa, Tanis Pieter J., Ponsioen Cyriel Y., D'Haens Geert R. A. M., Buskens Christianne J., Bemelman Willem A. Single-port versus multiport laparoscopic ileocecal resection for Crohn's disease Journal of Crohn s & colitis 2013;7 (10):e443-e448 [PubMed]
• Eshuis Emma J., Peters Charlotte P., van Bodegraven Adriaan A., Bartelsman Joep F., Bemelman Willem, Fockens Paul, D'Haens Geert R. A. M., Stokkers Pieter C. F., Ponsioen Cyriel Y. Ten Years of Infliximab for Crohn's Disease: Outcome in 469 Patients from 2 Tertiary Referral Centers Inflammatory bowel diseases 2013;19 (8):1622-1630 [PubMed]
• Feagan Brian G., Sandborn William J., D'Haens Geert, Pola Suresh, McDonald John W. D., Rutgeerts Paul, Munkholm Pia, Mittmann Ulrich, King Debra, Wong Cindy J., Zou Guangyong, Donner Allan, Shackelton Lisa M., Gilgen Denise, Nelson Sigrid, Vandervoort Margaret K., Fahmy Marianne, Loftus Edward V., Panaccione Remo, Travis Simon P., van Assche Gert A., Vermeire Séverine, Levesque Barrett G. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis Gastroenterology 2013;145 (1):149-157.e2 [PubMed]
• Ferrante Marc, Colombel Jean-Frederic, Sandborn William J., Reinisch Walter, Mantzaris Gerassimos J., Kornbluth Asher, Rachmilewitz Daniel, Lichtiger Simon, D'Haens Geert R., van der Woude Christien J., Danese Silvio, Diamond Robert H., Oortwijn Alessandra Faria, Tang Kezhen L., Miller Michael, Cornillie Freddy, Rutgeerts Paul J. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC Gastroenterology 2013;145 (5):978-986.e5 [PubMed]

2012

• Sandborn William J., van Assche Gert, Reinisch Walter, Colombel Jean-Frederic, D'Haens Geert, Wolf Douglas C., Kron Martina, Tighe Mary Beth, Lazar Andreas, Thakkar Roopal B. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis Gastroenterology 2012;142 (2):257-U150 [PubMed]
• Rutgeerts Paul, van Assche Gert, Sandborn William J., Wolf Douglas C., Geboes Karel, Colombel Jean-Frédéric, Reinisch Walter, Kumar Ashish, Lazar Andreas, Camez Anne, Lomax Kathleen G., Pollack Paul F., D'Haens Geert, Miehsler W., Baert F., van Assche G., van Gossum A., Enns R., Greenbloom S., MacIntosh D., Panaccione R., Colombel J.-F., Raedler A., Schreiber S., Zeitz M., Sostegni R., Stokkers P., Lofberg R., Barish C., Gordon G., Hanauer S., Hardi R., Katz S., McCabe R., Sandborn W. J., Wolf D. Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial Gastroenterology 2012;142 (5):1102-+ [PubMed]
• D'Haens Geert, Feagan Brian, Colombel Jean-Frédéric, Sandborn William J., Reinisch Walter, Rutgeerts Paul, Carbonnel Frank, Mary Jean-Yves, Danese Silvio, Fedorak Richard N., Hanauer Steven, Lémann Marc Challenges to the Design, Execution, and Analysis of Randomized Controlled Trials for Inflammatory Bowel Disease Gastroenterology 2012;143 (6):1461-1469 [PubMed]
• Peyrin-Biroulet Laurent, Billioud Vincent, D'Haens Geert, Panaccione Remo, Feagan Brian, Panés Julian, Danese Silvio, Schreiber Stefan, Ogata Haruhiko, Hibi Toshifumi, Higgins Peter D. R., Beaugerie Laurent, Chowers Yehuda, Louis Edouard, Steinwurz Flávio, Reinisch Walter, Rutgeerts Paul, Colombel Jean-Frédéric, Travis Simon, Sandborn William J. Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process American journal of gastroenterology 2012;107 (12):1770-1776 [PubMed]
• de Vos M., Dewit O., D'Haens G., Baert F., Fontaine F., Vermeire S., Franchimont D., Moreels T., Staessen D., Terriere L., Vander Cruyssen B., Louis E. Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis Journal of Crohn s & colitis 2012;6 (5):557-562 [PubMed]
• D'Haens Geert, Ferrante Marc, Vermeire Severine, Baert Filip, Noman Maja, Moortgat Liesbeth, Geens Patricia, Iwens Doreen, Aerden Isolde, van Assche Gert, van Olmen Gust, Rutgeerts Paul Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Inflammatory bowel diseases 2012;18 (12):2218-2224 [PubMed]
• Löwenberg Mark, D'Haens Geert Mucosal Healing in Crohn's Disease: Relevance for Clinical Outcomes Current drug targets 2012;13 (10):1248-1251 [PubMed]
• D'Haens Geert, Sandborn William J., Barrett Karen, Hodgson Ian, Streck Paul Once-Daily MMX (R) Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis American journal of gastroenterology 2012;107 (7):1064-1077 [PubMed]
• Feagan Brian G., Lémann Marc, Befrits Ragnar, Connell William, D'Haens Geert, Ghosh Subrata, Michetti Pierre, Ochsenkühn Thomas, Panaccione Remo, Schreiber Stefan, Silverberg Mark, Sorrentino Dario, van der Woude C. Janneke, Vermeire Severine, Rutgeerts Paul Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report Inflammatory bowel diseases 2012;18 (1):152-160 [PubMed]
• Reinisch Walter, van Assche Gert, Befrits Ragnar, Connell William, D'Haens Geert, Ghosh Subrata, Michetti Pierre, Ochsenkühn Thomas, Panaccione Remo, Schreiber Stefan, Silverberg Mark S., Sorrentino Dario, van der Woude C. Janneke, Vermeire Séverine, Panes Julian Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus Journal of Crohn s & colitis 2012;6 (2):248-258 [PubMed]
• Armuzzi Alessandro, van Assche Gert, Reinisch Walter, Pineton de Chambrun Guillaume, Griffiths Anne, Sladek Malgorzata, Preiss Jan C., Lukas Milan, D'Haens Geert Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease Journal of Crohn s & colitis 2012;6 (4):492-502 [PubMed]
• Gardenbroek T. J., Eshuis E. J., Ponsioen C. I. J., Ubbink D. T., D'Haens G. R. A. M., Bemelman W. A. The effect of appendectomy on the course of ulcerative colitis: a systematic review Colorectal disease 2012;14 (5):545-553 [PubMed]
• D'Haens Geert The Ideal World of Clinical Trials: Far From Reality Clinical gastroenterology and hepatology 2012;10 (9):1008 [PubMed]
• Sandborn William J., Gasink Christopher, Gao Long-Long, Blank Marion A., Johanns Jewel, Guzzo Cynthia, Sands Bruce E., Hanauer Stephen B., Targan Stephan, Rutgeerts Paul, Ghosh Subrata, de Villiers Willem J. S., Panaccione Remo, Greenberg Gordon, Schreiber Stefan, Lichtiger Simon, Feagan Brian G., Haas T., Kaser A., Vogelsang H., Brown S., Florin T., Gibson P. G., Hetzel D., Leong R., Pavli P., Radford-Smith G., Sparrow M., Baert F., D'Haens G., D'Heygere F., Franchimont D., Louis E., Mana F., Moreels T., Vermeire S., Anderson F., Axler J., Greenbloom S., Bitton A., Fedorak R. N., Larkai E., Marshall J., Singh R., Abitbol V., Allez M., Lemann Marc, Bonaz B., Ponsioen C. Y., Stokkers Pieter Ustekinumab induction and maintenance therapy in refractory Crohn's disease New England journal of medicine 2012;367 (16):1519-1528 [PubMed]
• Ghosh Subrata, D'Haens Geert, Feagan Brian G., Silverberg Mark S., Szigethy Eva M. What do changes in inflammatory bowel disease management mean for our patients? Journal of Crohn s & colitis 2012;6 (2):S243-S249 [PubMed]

2011

• Reinisch Walter, Sandborn William J., Hommes Daniel W., D'Haens Geert, Hanauer Stephen, Schreiber Stefan, Panaccione Remo, Fedorak Richard N., Tighe Mary Beth, Huang Bidan, Kampman Wendy, Lazar Andreas, Thakkar Roopal Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Gut 2011;60 (6):780-787 [PubMed]
• Sandborn William J., Schreiber Stefan, Feagan Brian G., Rutgeerts Paul, Younes Ziad H., Bloomfield Ralph, Coteur Geoffroy, Guzman Juan Pablo, D'Haens Geert R. Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial Clinical gastroenterology and hepatology 2011;9 (8):670-678.e3 [PubMed]
• Ochsenkühn Thomas, D'Haens Geert Current misunderstandings in the management of ulcerative colitis Gut 2011;60 (9):1294-1299 [PubMed]
• Pariente Benjamin, Cosnes Jacques, Danese Silvio, Sandborn William J., Lewin Maïté, Fletcher Joel G., Chowers Yehuda, D'Haens Geert, Feagan Brian G., Hibi Toshifumi, Hommes Daniel W., Irvine E. Jan, Kamm Michael A., Loftus Edward V., Louis Edouard, Michetti Pierre, Munkholm Pia, Oresland Tom, Panés Julian, Peyrin-Biroulet Laurent, Reinisch Walter, Sands Bruce E., Schoelmerich Juergen, Schreiber Stefan, Tilg Herbert, Travis Simon, van Assche Gert, Vecchi Maurizio, Mary Jean-Yves, Colombel Jean-Frédéric, Lémann Marc Development of the Crohn's disease digestive damage score, the Lémann score Inflammatory bowel diseases 2011;17 (6):1415-1422 [PubMed]
• Baumgart Daniel C., Bernstein Charles N., Abbas Zaigham, Colombel Jean F., Day Andrew S., D'Haens Geert, Dotan Iris, Goh Khean L., Hibi Toshifumi, Kozarek Richard A., Quigley Eamonn M. M., Reinisch Walter, Sands Bruce E., Sollano Jose D., Steinhart A. Hillary, Steinwurz Flávio, Vatn Morten H., Yamamoto-Furusho Jesús K. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting Inflammatory bowel diseases 2011;17 (2):639-644 [PubMed]
• Travis S. P. L., Higgins P. D. R., Orchard T., van der Woude C. J., Panaccione R., Bitton A., O'Morain C., Panés J., Sturm A., Reinisch W., Kamm M. A., D'Haens G. Review article: defining remission in ulcerative colitis Alimentary pharmacology & therapeutics 2011;34 (2):113-124 [PubMed]
• D'Haens Geert R., Panaccione Remo, Higgins Peter D. R., Vermeire Severine, Gassull Miquel, Chowers Yehuda, Hanauer Stephen B., Herfarth Hans, Hommes Daan W., Kamm Michael, Löfberg Robert, Quary A., Sands Bruce, Sood A., Watermayer G., Lashner Bret, Lémann Marc, Plevy Scott, Reinisch Walter, Schreiber Stefan, Siegel Corey, Targan Stephen, Watanabe M., Feagan Brian, Sandborn William J., Colombel Jean Frédéric, Travis Simon The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response American journal of gastroenterology 2011;106 (2):199-212 [PubMed]

2010

• Panaccione R., Colombel J.-F., Sandborn W. J., Rutgeerts P., D'Haens G. R., Robinson A. M., Chao J., Mulani P. M., Pollack P. F. Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease Alimentary pharmacology & therapeutics 2010;31 (12):1296-1309 [PubMed]
• D'Haens Geert Anti-TNF treatment in Crohn's disease: toward tailored therapy? American journal of gastroenterology 2010;105 (5):1140-1141 [PubMed]
• Ulenaers M., Buchel O. C., van Olmen A., Moons V., D'Haens G., Christiaens P. An uncommon cause of visceral arterial embolism in patients presenting with acute abdominal pain: a report of 2 cases Acta gastro-enterologica Belgica 2010;73 (1):55-60 [PubMed]
• Sandborn William J., Abreu Maria T., D'Haens Geert, Colombel Jean-Frédéric, Vermeire Severine, Mitchev Krassimir, Jamoul Corinne, Fedorak Richard N., Spehlmann Martina E., Wolf Douglas C., Lee Scott, Rutgeerts Paul Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab Clinical gastroenterology and hepatology 2010;8 (8):688-695.e2 [PubMed]
• D'Haens G. R., Kovács A., Vergauwe P., Nagy F., Molnár T., Bouhnik Y., Weiss W., Brunner H., Lavergne-Slove A., Binelli D., Di Stefano A. F. D., Marteau P. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis Journal of Crohn s & colitis 2010;4 (2):153-160 [PubMed]
• Ferrante Marc, D'Haens Geert, Dewit Olivier, Baert Filip, Holvoet Jan, Geboes Karel, de Hertogh Gert, van Assche Gert, Vermeire Séverine, Rutgeerts Paul Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series Inflammatory bowel diseases 2010;16 (2):243-249 [PubMed]
• Colombel Jean Frédéric, Sandborn William J., Reinisch Walter, Mantzaris Gerassimos J., Kornbluth Asher, Rachmilewitz Daniel, Lichtiger Simon, D'Haens Geert, Diamond Robert H., Broussard Delma L., Tang Kezhen L., van der Woude C. Janneke, Rutgeerts Paul, Ahluwalia N., Antonson C., Arnold G., Astroff M., Aumais G., Baert F., Bassan I., Becker S., Befrits R., Bendtsen F., Bigard M., Bokemeyer B., Bologna S., Bonaz B., Bradette M., Braun R., Cappa J., Colombel J. F., Dahlerup J., Denton W., Deus J., Dewit O., Dignass A., Sturm A., Dimitroff J., Dolin B., Dotan I., Dupas J., Eliakim A., Fallingborg J., Fleisher M., Fraser G., Goff J., Gonzalez V., Menchen Viso L., Gordon G., Ghosh S. Infliximab, azathioprine, or combination therapy for Crohn's disease New England journal of medicine 2010;362 (15):1383-1395 [PubMed]
• Baert Filip, Moortgat Liesbeth, van Assche Gert, Caenepeel Philip, Vergauwe Philippe, de Vos Martine, Stokkers Pieter, Hommes Daniel, Rutgeerts Paul, Vermeire Severine, D'Haens Geert, Baert F., Caenepeel Ph, Coche J. C., de Vos M., Fontaine F., Lambrecht G., Louis E., Mana F., Ochsenkühn T., van Hooteghem P., Rutgeerts P., Simoens M., Tuynman H., van de Mierop F., Vergauwe P. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease Gastroenterology 2010;138 (2):463-8; quiz e10-1 [PubMed]
• van der Woude C. Janneke, Stokkers Pieter, van Bodegraven Ad A., van Assche Gert, Hebzda Zbigniew, Paradowski Leszek, D'Haens Geert, Ghosh Subrata, Feagan Brian, Rutgeerts Paul, Dijkstra Gerard, de Jong Dirk J., Oldenburg Bas, Farhan Mahdi, Richard Tristan, Dean Yann, Hommes Daniel W. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease Inflammatory bowel diseases 2010;16 (10):1708-1716 [PubMed]
• Rahier J. F., Moreels T., de Munter P., D'Haens G. Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium Acta gastro-enterologica Belgica 2010;73 (1):41-45 [PubMed]
• Holtmann Martin H., Krummenauer Frank, Claas Christina, Kremeyer Kristina, Lorenz Dirk, Rainer Olivia, Vogel Iris, Böcker Ulrich, Böhm Stephan, Büning Carsten, Duchmann Rainer, Gerken Guido, Herfarth Hans, Lügering Norbert, Kruis Wolfgang, Reinshagen Max, Schmidt Jan, Stallmach Andreas, Stein Jürgen, Sturm Andreas, Galle Peter R., Hommes Daan W., D'Haens Geert, Rutgeerts Paul, Neurath Markus F. Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients Digestive diseases and sciences 2010;55 (4):1066-1078 [PubMed]
• van Assche Gert, Dignass Axel, Reinisch Walter, van der Woude C. Janneke, Sturm Andreas, de Vos Martine, Guslandi Mario, Oldenburg Bas, Dotan Iris, Marteau Philippe, Ardizzone Alessandro, Baumgart Daniel C., D'Haens Geert, Gionchetti Paolo, Portela Francisco, Vucelic Boris, Söderholm Johan, Escher Johanna, Koletzko Sibylle, Kolho Kaija-Leena, Lukas Milan, Mottet Christian, Tilg Herbert, Vermeire Séverine, Carbonnel Frank, Cole Andrew, Novacek Gottfried, Reinshagen Max, Tsianos Epameinondas, Herrlinger Klaus, Bouhnik Yoram, Kiesslich Ralf, Stange Eduard, Travis Simon, Lindsay James, Cole A., Ardizzone A., Baumgart D., Bouhnik Y., Carbonnel F., de Vos M., Dignass A., Dotan I., Escher J. C., Gionchetti P., Guslandi M., Herrlinger K., Kiesslich R., Koletzko S., Kolho K.-L. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Journal of Crohn s & colitis 2010;4 (1):63-101 [PubMed]
• D'Haens Geert R. Top-down therapy for IBD: rationale and requisite evidence Nature reviews. Gastroenterology & hepatology 2010;7 (2):86-92 [PubMed]

2009

• Colombel J.-F., Schwartz D. A., Sandborn W. J., Kamm M. A., D'Haens G., Rutgeerts P., Enns R., Panaccione R., Schreiber S., Li J., Kent J. D., Lomax K. G., Pollack P. F. Adalimumab for the treatment of fistulas in patients with Crohn's disease Gut 2009;58 (7):940-948 [PubMed]
• D'Haens G. Anti-TNF-alpha treatment strategies: results and clinical perspectives Gastroenterologie clinique et biologique 2009;33 (Suppl. 3):S209-S216 [PubMed]
• Peyrin-Biroulet Laurent, Deltenre Pierre, Ardizzone Sandro, D'Haens Geert, Hanauer Stephen B., Herfarth Hans, Lémann Marc, Colombel Jean-Frédéric Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis American journal of gastroenterology 2009;104 (8):2089-2096 [PubMed]
• van Cutsem Eric, Köhne Claus-Henning, Hitre Erika, Zaluski Jerzy, Chang Chien Chung-Rong, Makhson Anatoly, D'Haens Geert, Pintér Tamás, Lim Robert, Bodoky György, Roh Jae Kyung, Folprecht Gunnar, Ruff Paul, Stroh Christopher, Tejpar Sabine, Schlichting Michael, Nippgen Johannes, Rougier Philippe Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer New England journal of medicine 2009;360 (14):1408-1417 [PubMed]
• Pardi Darrell S., D'Haens Geert, Shen Bo, Campbell Simon, Gionchetti Paolo Clinical guidelines for the management of pouchitis Inflammatory bowel diseases 2009;15 (9):1424-1431 [PubMed]
• Vakil Nimish, Talley Nicholas, van Zanten Sander Veldhuyzen, Flook Nigel, Persson Tore, Björck Ewa, Lind Tore, Bolling-Sternevald Elisabeth, Bai J. C., Segal E., Di Risio C., Pedrana R., Rainoldi J., Milutin M., Palazzo F., Macken E., Baetens P., D'Haens G., Cabooter M., Martinet J. P., Delwaide J., Piessevaux H., Buset M., Janssens J., Vergauwe P., Pollet S., Quilici F., Rodriguez T. N., da Silva E. P., Nader F., Luiz Jorge J., Achilles P., Corréa B. L., Guedes J., Clark D., Plourde A. N., Desai M., Morgan E. P., Gray J., Cohen A., Reddy S., Jobin G., Sadowski D., Kelly A., Morgan D., Ing G., Liang W., Tytus R., Teitelbaum I., Lasko B. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms Clinical gastroenterology and hepatology 2009;7 (7):756-761 [PubMed]
• D'Haens Geert R., Fedorak Richard, Lémann Marc, Feagan Brian G., Kamm Michael A., Cosnes Jacques, Rutgeerts Paul J., Marteau Philippe, Travis Simon, Schölmerich Jürgen, Hanauer Steven, Sandborn William J. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease Inflammatory bowel diseases 2009;15 (10):1599-1604 [PubMed]
• Rahier J. F., Ben-Horin S., Chowers Y., Conlon C., de Munter P., D'Haens G., Domènech E., Eliakim R., Eser A., Frater J., Gassull M., Giladi M., Kaser A., Lémann M., Moreels T., Moschen A., Pollok R., Reinisch W., Schunter M., Stange E. F., Tilg H., van Assche G., Viget N., Vucelic B., Walsh A., Weiss G., Yazdanpanah Y., Zabana Y., Travis S. P. L., Colombel J. F. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Journal of Crohn s & colitis 2009;3 (2):47-91 [PubMed]
• D'Haens Geert, Rutgeerts Paul Immunosuppression-associated lymphoma in IBD Lancet 2009;374 (9701):1572-1573 [PubMed]
• Ferrante Marc, D'Haens Geert, Rutgeerts Paul, Vermeire Séverine, van Assche Gert Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease) Current gastroenterology reports 2009;11 (6):504-508 [PubMed]
• Macken E., Moreels T., Pelckmans P., Peeters M., Baert D., Reynaert H., Delooze D., Vannoote J., Hiele M., Coenegrachts J. L., Hoste P., van Cutsem E., D'Haens G. Quality assurance and recommendations for quality assessment of screening colonoscopy in Belgium Acta gastro-enterologica Belgica 2009;72 (1):17-25 [PubMed]
• D'Haens G. R. Top-down therapy for Crohn's disease: rationale and evidence Acta clinica Belgica 2009;64 (6):540-546 [PubMed]

2008

• Kulnigg Stefanie, Stoinov Simeon, Simanenkov Vladimir, Dudar Larisa V., Karnafel Waldemar, Garcia Luis Chaires, Sambuelli Alicia M., D'Haens Geert, Gasche Christoph A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial American journal of gastroenterology 2008;103 (5):1182-1192 [PubMed]
• van Gool Stijn, van Casteren Lieve, Buchel Otto, Frans Eric, Dedeurwaerdere Francisca, van Olmen August, D'Haens Geert, Moons Veerle, Christiaens Paul Cytomegalovirus colitis in an apparently immunecompetent host after biliopancreatic diversion for obesity Acta gastro-enterologica Belgica 2008;71 (4):423-426 [PubMed]
• D'Haens Geert, Baert Filip, van Assche Gert, Caenepeel Philip, Vergauwe Philippe, Tuynman Hans, de Vos Martine, van Deventer Sander, Stitt Larry, Donner Allan, Vermeire Severine, van de Mierop Frank J., Coche Jean-Charles R., van der Woude Janneke, Ochsenkühn Thomas, van Bodegraven Ad A., van Hootegem Philippe P., Lambrecht Guy L., Mana Fazia, Rutgeerts Paul, Feagan Brian G., Hommes Daniel Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Lancet 2008;371 (9613):660-667 [PubMed]
• Feagan Brian G., Panaccione Remo, Sandborn William J., D'Haens Geert R., Schreiber Stefan, Rutgeerts Paul J., Loftus Edward V., Lomax Kathleen G., Yu Andrew P., Wu Eric Q., Chao Jingdong, Mulani Parvez Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study Gastroenterology 2008;135 (5):1493-1499 [PubMed]
• Christiaens Paul, Decock Sofie, Buchel Otto, Bulté Katrien, Moons Veerle, D'Haens Geert, van Olmen Gust Endoscopic trimming of metallic stents with the use of argon plasma Gastrointestinal endoscopy 2008;67 (2):369-371 [PubMed]
• Travis S. P. L., Stange E. F., Lémann M., Oresland T., Bemelman W. A., Chowers Y., Colombel J. F., D'Haens G., Ghosh S., Marteau P., Kruis W., Mortensen N. J. McC, Penninckx F., Gassull M. European evidence-based Consensus on the management of ulcerative colitis: Current management Journal of Crohn s & colitis 2008;2 (1):24-62 [PubMed]
• Cortot Antoine, Maetz Denis, Degoutte Eric, Delette Olivier, Meunier Pierre, Tan Gie, Cazals Jean-Brice, Dewit Olivier, Hebuterne Xavier, Beorchia Sylvain, Grunberg Bernard, Leprince Eric, D'Haens Geert, Forestier Sylvie, Idier Isabelle, Lémann Marc Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis American journal of gastroenterology 2008;103 (12):3106-3114 [PubMed]
• Feagan Brian G., Sandborn William J., Mittmann Ulrich, Bar-Meir Simon, D'Haens Geert, Bradette Marc, Cohen Albert, Dallaire Chrystian, Ponich Terry P., McDonald John W. D., Hébuterne Xavier, Paré Pierre, Klvana Pavel, Niv Yaron, Ardizzone Sandro, Alexeeva Olga, Rostom Alaa, Kiudelis Gediminas, Spleiss Johannes, Gilgen Denise, Vandervoort Margaret K., Wong Cindy J., Zou Guang Yong, Donner Allan, Rutgeerts Paul Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials JAMA 2008;299 (14):1690-1697 [PubMed]
• D'Haens Geert R., Vermeire Severine, van Assche Gert, Noman Maja, Aerden Isolde, van Olmen Gust, Rutgeerts Paul Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial Gastroenterology 2008;135 (4):1123-1129 [PubMed]
• van Assche Gert, Magdelaine-Beuzelin Charlotte, D'Haens Geert, Baert Filip, Noman Maja, Vermeire Séverine, Ternant David, Watier Hervé, Paintaud Gilles, Rutgeerts Paul Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial Gastroenterology 2008;134 (7):1861-1868 [PubMed]

2007

• Sandborn William J., Rutgeerts Paul, Enns Robert, Hanauer Stephen B., Colombel Jean-Frédéric, Panaccione Remo, D'Haens Geert, Li Ju, Rosenfeld Marie R., Kent Jeffrey D., Pollack Paul F. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial Annals of internal medicine 2007;146 (12):829-838 [PubMed]
• D'Haens Geert, Sandborn William J., Feagan Brian G., Geboes Karel, Hanauer Stephen B., Irvine E. Jan, Lémann Marc, Marteau Philippe, Rutgeerts Paul, Schölmerich Jurgen, Sutherland Lloyd R. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 2007;132 (2):763-786 [PubMed]
• Vermeire Severine, Noman Maja, van Assche Gert, Baert Filip, D'Haens Geert, Rutgeerts Paul Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease Gut 2007;56 (9):1226-1231 [PubMed]
• Eleftheriadis N., Lambrecht G., D'Haens G., Baert F., Cabooter M., Louis E., Assche G. Van, Schurmans P., Caenepeel P., Outryve M. Van, Lammens P., Gossum A. Van, de Vos M. Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis Journal of Crohn s & colitis 2007;1 (1):21-27 [PubMed]
• D'Haens Geert Risks and benefits of biologic therapy for inflammatory bowel diseases Gut 2007;56 (5):725-732 [PubMed]
• Louis Eduard, Boverie Jacques, Dewit Olivier, Baert Filip, de Vos Martine, D'Haens Geert Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study Acta gastro-enterologica Belgica 2007;70 (1):15-19 [PubMed]
• Christiaens P., de Roock W., van Olmen A., Moons V., D'Haens G. Treatment of Zenker's diverticulum through a flexible endoscope with a transparent oblique-end hood attached to the tip and a monopolar forceps Endoscopy 2007;39 (2):137-140 [PubMed]

2006

• D'Haens Geert, Daperno Marco Advances in biologic therapy for ulcerative colitis and Crohn's disease Current gastroenterology reports 2006;8 (6):506-512 [PubMed]
• Louis E., Jorissen P., Bastens B., D'Haens G., Schoofs N., Burette A., Christiaens P., Tack J. Atypical symptoms of GORD in Belgium: epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month Acta gastro-enterologica Belgica 2006;69 (2):203-208 [PubMed]
• D'Haens Geert Dysplasia and cancer in ulcerative colitis: too many questions, too few answers Digestion 2006;73 (1):9-10 [PubMed]
• Travis S. P. L., Stange E. F., Lémann M., Oresland T., Chowers Y., Forbes A., D'Haens G., Kitis G., Cortot A., Prantera C., Marteau P., Colombel J.-F., Gionchetti P., Bouhnik Y., Tiret E., Kroesen J., Starlinger M., Mortensen N. J. European evidence based consensus on the diagnosis and management of Crohn's disease: current management Gut 2006;55 (Suppl. 1):i16-i35 [PubMed]
• Hommes D. W., Mikhajlova T. L., Stoinov S., Stimac D., Vucelic B., Lonovics J., Zákuciová M., D'Haens G., van Assche G., Ba S., Lee S., Pearce T. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease Gut 2006;55 (8):1131-1137 [PubMed]
• Holtmann Martin H., Krummenauer Frank, Claas Christina, Kremeyer Kristina, Lorenz Dirk, Rainer Olivia, Vogel Iris, Böcker Ulrich, Böhm Stephan, Büning Carsten, Duchmann Rainer, Gerken Guido, Herfarth Hans, Lügering Norbert, Kruis Wolfgang, Reinshagen Max, Schmidt Jan, Stallmach Andreas, Stein Jürgen, Sturm Andreas, Galle Peter R., Hommes Daan W., D'Haens Geert, Rutgeerts Paul, Neurath Markus F. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients Digestive diseases and sciences 2006;51 (9):1516-1524 [PubMed]
• D'Haens G., Hommes D., Engels L., Baert F., van der Waaij L., Connor P., Ramage J., Dewit O., Palmen M., Stephenson D., Joseph R. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study Alimentary pharmacology & therapeutics 2006;24 (7):1087-1097 [PubMed]
• Schreiber Stefan, Feagan Brian, D'Haens Geert, Colombel Jean-Frederic, Geboes Karel, Yurcov Mikhail, Isakov Vasily, Golovenko Oleg, Bernstein Charles N., Ludwig Diether, Winter Trevor, Meier Ulrich, Yong Chan, Steffgen Jürgen Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial Clinical gastroenterology and hepatology 2006;4 (3):325-334 [PubMed]
• Ferrante Marc, de Hertogh Gert, Hlavaty Tibor, D'Haens Geert, Penninckx Freddy, D'Hoore Andre, Vermeire Séverine, Rutgeerts Paul, Geboes Karel, van Assche Gert The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence Gastroenterology 2006;130 (6):1595-1606 [PubMed]

2005

• D'Haens Geert Infliximab for ulcerative colitis: finally some answers Gastroenterology 2005;128 (7):2161-2164 [PubMed]
• Rutgeerts Paul, van Assche Gert, Vermeire Séverine, D'Haens Geert, Baert Filip, Noman Maja, Aerden Isolde, de Hertogh Gert, Geboes Karel, Hiele Martin, D'Hoore Andre, Penninckx Freddy Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial Gastroenterology 2005;128 (4):856-861 [PubMed]

2004

• D'Haens Geert, Hlavaty Tibor Advances in medical therapy for Crohn's disease Current gastroenterology reports 2004;6 (6):496-505 [PubMed]
• Daperno Marco, D'Haens Geert, van Assche Gert, Baert Filip, Bulois Philippe, Maunoury Vincent, Sostegni Raffaello, Rocca Rodolfo, Pera Angelo, Gevers Annemie, Mary Jean-Yves, Colombel Jean-Frédéric, Rutgeerts Paul Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD Gastrointestinal endoscopy 2004;60 (4):505-512 [PubMed]
• Arts Joris, D'Haens Geert, Zeegers Miranda, van Assche Gert, Hiele Martin, D'Hoore André, Penninckx Freddy, Vermeire Severine, Rutgeerts Paul Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis Inflammatory bowel diseases 2004;10 (2):73-78 [PubMed]
• Baert F., Vermeire S., Noman M., van Assche G., D'Haens G., Rutgeerts P. Management of ulcerative colitis and Crohn's disease Acta clinica Belgica 2004;59 (5):304-314 [PubMed]
• D'Haens G., van Bodegraven A. A. Mesalazine is safe for the treatment of IBD Gut 2004;53 (1):155 [PubMed]
• D'Haens Geert Mucosal healing in pediatric Crohn's disease: the goal of medical treatment Inflammatory bowel diseases 2004;10 (4):479-480 [PubMed]
• Elseviers M. M., D'Haens G., Lerebours E., Plane C., Stolear J. C., Riegler G., Capasso G., van Outryve M., Mishevska-Mukaetova P., Djuranovic S., Pelckmans P., de Broe M. E. Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy? Clinical nephrology 2004;61 (2):83-89 [PubMed]
• Marchal L., D'Haens G., van Assche G., Vermeire S., Noman M., Ferrante M., Hiele M., Bueno de Mesquita M., D'Hoore A., Penninckx F., Rutgeerts P. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study Alimentary pharmacology & therapeutics 2004;19 (7):749-754 [PubMed]

2003

• D'Haens Geert Anti-TNF therapy for Crohn's disease Current pharmaceutical design 2003;9 (4):289-294 [PubMed]
• Tilg H., Vogelsang H., Ludwiczek O., Lochs H., Kaser A., Colombel J.-F., Ulmer H., Rutgeerts P., Krüger S., Cortot A., D'Haens G., Harrer M., Gasche C., Wrba F., Kuhn I., Reinisch W. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis Gut 2003;52 (12):1728-1733 [PubMed]
• D'Haens Geert R. Infliximab as disease-modifying therapy European journal of gastroenterology & hepatology 2003;15 (3):233-237 [PubMed]
• Baert Filip, Noman Maja, Vermeire Severine, van Assche Gert, D'Haens Geert, Carbonez An, Rutgeerts Paul Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease New England journal of medicine 2003;348 (7):601-608 [PubMed]
• van Assche Gert, D'Haens Geert, Noman Maja, Vermeire Séverine, Hiele Martin, Asnong Katrien, Arts Joris, D'Hoore Andre, Penninckx Freddy, Rutgeerts Paul Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis Gastroenterology 2003;125 (4):1025-1031 [PubMed]

2002

• D'Haens Geert, Daperno Marco Advances in medical therapy for Crohn's disease Current gastroenterology reports 2002;4 (6):506-512 [PubMed]
• Louis E., Vermeire S., Rutgeerts P., de Vos M., van Gossum A., Pescatore P., Fiasse R., Pelckmans P., Reynaert H., D'Haens G., Malaise M., Belaiche J. A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism Scandinavian journal of gastroenterology 2002;37 (7):818-824 [PubMed]
• Baert Filip, Schmit Alain, D'Haens Geert, Dedeurwaerdere Franceska, Louis Edouard, Cabooter Marc, de Vos Martine, Fontaine Fernand, Naegels Serge, Schurmans Piet, Stals Hedwig, Geboes Karel, Rutgeerts Paul Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up Gastroenterology 2002;122 (1):20-25 [PubMed]
• Vermeire Severine, Louis Edouard, Carbonez An, van Assche Gert, Noman Maja, Belaiche Jacques, de Vos Martine, van Gossum Andre, Pescatore Paul, Fiasse Rene, Pelckmans Paul, Reynaert Hendrik, D'Haens Geert, Rutgeerts Paul Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease American journal of gastroenterology 2002;97 (9):2357-2363 [PubMed]
• van Assche Gert, Baert Filip, de Reuck Marc, de Vos Martine, de Wit Olivier, Hoang Pierre, Louis Edouard, Mana Fazia, Pelckmans Paul, Rutgeerts Paul, van Gossum Andre, D'Haens Geert The role of aminosalicylates in the treatment of ulcerative colitis Acta gastro-enterologica Belgica 2002;65 (4):196-199 [PubMed]

2001

• D'Haens G., Swijsen C., Noman M., Lemmens L., Ceuppens J., Agbahiwe H., Geboes K., Rutgeerts P. Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial American journal of gastroenterology 2001;96 (9):2564-2568 [PubMed]
• Cornillie F., Shealy D., D'Haens G., Geboes K., van Assche G., Ceuppens J., Wagner C., Schaible T., Plevy S. E., Targan S. R., Rutgeerts P. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease Alimentary pharmacology & therapeutics 2001;15 (4):463-473 [PubMed]
• D'Haens G., Lemmens L., Geboes K., Vandeputte L., van Acker F., Mortelmans L., Peeters M., Vermeire S., Penninckx F., Nevens F., Hiele M., Rutgeerts P. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis Gastroenterology 2001;120 (6):1323-1329 [PubMed]
• Bennink R., Peeters M., D'Haens G., Rutgeerts P., Mortelmans L. Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis Clinical nuclear medicine 2001;26 (2):99-104 [PubMed]
• D'Haens G. R. Tissue effects of anti-TNF therapies Acta gastro-enterologica Belgica 2001;64 (2):173-176 [PubMed]

2000

• Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S. B., Irvine E. J., Jewell D. P., Rachmilewitz D., Sachar D. B., Sandborn W. J., Sutherland L. R. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 Inflammatory bowel diseases 2000;6 (1):8-15 [PubMed]
• Craninx M., D'Haens G., Cokelaere K., Baert F., Penninckx F., D'Hoore A., Ectors N., Rutgeerts P., Geboes K. Crohn's disease and intestinal endometriosis: an intriguing co-existence European journal of gastroenterology & hepatology 2000;12 (2):217-221 [PubMed]
• Liu Z., Geboes K., Colpaert S., D'Haens G. R., Rutgeerts P., Ceuppens J. L. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production Journal of immunology (Baltimore, Md. 2000;164 (7):3608-3615 [PubMed]
• D'Haens G. Infliximab (Remicade): the magic bullet for Crohn's disease? Digestive and liver disease 2000;32 (8):653-656 [PubMed]
• D'Haens G. Medical management of major internal fistulae in Crohn's disease Inflammatory bowel diseases 2000;6 (3):244-245 [PubMed]
• Rampton D. S., Neurath M. F., Almer S., D'Haens G., Petritsch W., Stange E. F. Mycophenolate mofetil in Crohn's disease Lancet 2000;356 (9224):163-164 [PubMed]
• Liu Z., Geboes K., Colpaert S., Overbergh L., Mathieu C., Heremans H., de Boer M., Boon L., D'Haens G., Rutgeerts P., Ceuppens J. L. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions Journal of immunology (Baltimore, Md. 2000;164 (11):6005-6014 [PubMed]
• Melange M., D'Haens G., Devos M., Kartheuser A., Louis E., Pattyn P., Pelckmans P., Penninckx F., Potvin P., Schapira M., van de Stadt J., van Gossum A. V. The medical management of severe acute and chronic ulcerative colitis--current recommendations from the Belgian Working Group Acta gastro-enterologica Belgica 2000;63 (3):273-274 [PubMed]

1999

• Belaiche J., Louis E., D'Haens G., Cabooter M., Naegels S., de Vos M., Fontaine F., Schurmans P., Baert F., de Reuck M., Fiasse R., Holvoet J., Schmit A., van Outryve M. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group American journal of gastroenterology 1999;94 (8):2177-2181 [PubMed]
• Rutgeerts P., D'Haens G., Targan S., Vasiliauskas E., Hanauer S. B., Present D. H., Mayer L., van Hogezand R. A., Braakman T., DeWoody K. L., Schaible T. F., van Deventer S. J. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease Gastroenterology 1999;117 (4):761-769 [PubMed]
• D'Haens G., van Deventer S., van Hogezand R., Chalmers D., Kothe C., Baert F., Braakman T., Schaible T., Geboes K., Rutgeerts P. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial Gastroenterology 1999;116 (5):1029-1034 [PubMed]
• D'Haens G., Geboes K., Rutgeerts P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine Gastrointestinal endoscopy 1999;50 (5):667-671 [PubMed]
• Liu Z., Colpaert S., D'Haens G. R., Kasran A., de Boer M., Rutgeerts P., Geboes K., Ceuppens J. L. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production Journal of immunology (Baltimore, Md. 1999;163 (7):4049-4057 [PubMed]
• D'Haens G. R. Infliximab (Remicade), a new biological treatment for Crohn's disease Italian journal of gastroenterology and hepatology 1999;31 (6):519-520 [PubMed]
• Baert F., Wouters K., D'Haens G., Hoang P., Naegels S., D'Heygere F., Holvoet J., Louis E., Devos M., Geboes K. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis Gut 1999;45 (3):375-381 [PubMed]
• Vandeputte L., D'Haens G., Baert F., Rutgeerts P. Methotrexate in refractory Crohn's disease Inflammatory bowel diseases 1999;5 (1):11-15 [PubMed]
• D'Haens G., Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention Inflammatory bowel diseases 1999;5 (4):295-303 [PubMed]
• D'Haens G. Prevention of postoperative recurrence in Crohn's disease Current gastroenterology reports 1999;1 (6):476-481 [PubMed]
• Baert F. J., D'Haens G. R., Peeters M., Hiele M. I., Schaible T. F., Shealy D., Geboes K., Rutgeerts P. J. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis Gastroenterology 1999;116 (1):22-28 [PubMed]

1998

• D'Haens G., Verstraete A., Cheyns K., Aerden I., Bouillon R., Rutgeerts P. Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease Alimentary pharmacology & therapeutics 1998;12 (5):419-424 [PubMed]
• D'Haens G. R., Geboes K., Peeters M., Baert F., Penninckx F., Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 1998;114 (2):262-267 [PubMed]
• Geboes K., Ectors N., D'Haens G., Rutgeerts P. Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease? American journal of gastroenterology 1998;93 (2):201-206 [PubMed]
• D'Haens G., Suenaert P., Westhovens R., Rutgeerts P. Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine Inflammatory bowel diseases 1998;4 (1):27-28 [PubMed]

1997

• D'Haens G., Geboes K., Ponette E., Penninckx F., Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease Gastroenterology 1997;112 (5):1475-1481 [PubMed]
• D'Haens G., Geboes K., Peeters M., Baert F., Ectors N., Rutgeerts P. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study American journal of gastroenterology 1997;92 (8):1275-1279 [PubMed]
• van Gossum A., Schmit A., Adler M., Chioccioli C., Fiasse R., Louwagie P., D'Haens G., Rutgeerts P., de Vos M., Reynaert H., Devis G., Belaiche J., van Outryve M. Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group Acta gastro-enterologica Belgica 1997;60 (3):197-200 [PubMed]

1995

• D'Haens G. R., Gasparaitis A. E., Hanauer S. B. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease Gut 1995;36 (5):715-717 [PubMed]
• Peetermans W. E., D'Haens G. R., Ceuppens J. L., Rutgeerts P., Geboes K. Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease Gastroenterology 1995;108 (1):75-82 [PubMed]

1994

• Rutgeerts P., D'Haens G., Hiele M., Geboes K., Vantrappen G. Appendectomy protects against ulcerative colitis Gastroenterology 1994;106 (5):1251-1253 [PubMed]
• D'Haens G., Hiele M., Rutgeerts P., Geboes K., Ceuppens J. L. Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection Gut 1994;35 (12):1728-1733 [PubMed]
• D'Haens G. R., Rutgeerts P. J. Postoperative recurrence of Crohn's disease: pathogenesis and prevention Acta gastro-enterologica Belgica 1994;57 (5-6):311-313 [PubMed]
• D'Haens G., Rutgeerts P., Geboes K., Vantrappen G. The natural history of esophageal Crohn's disease: three patterns of evolution Gastrointestinal endoscopy 1994;40 (3):296-300 [PubMed]

1993

• D'Haens G. R., Ruchim M. A., Goldberg M. J., Baker A. L. Massive intra-hepatic and extra-hepatic bile cast formation after cholecystectomy Gastrointestinal endoscopy 1993;39 (4):579-581 [PubMed]
• D'Haens G. R., Lashner B. A., Hanauer S. B. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis American journal of gastroenterology 1993;88 (8):1174-1178 [PubMed]
• D'Haens G., Breysem Y., Rutgeerts P., van Besien B., Geboes K., Ponette E., Vantrappen G. Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories Journal of clinical gastroenterology 1993;17 (3):207-212 [PubMed]